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 Genetische Analyse und Expressionstudie zu Kandidatengenen, die die Merkmale der 
Beinschwäche beim Schwein beeinflussen 
 
Beinschwäche Probleme sind von großer Bedeutung in der Schweinezucht Industrie, 
besonders im Bezug auf den Tierschutz. Diese Studie wurde durchgeführt, um chromosomale 
Regionen und Kandidatengene, die die Beinschwäche-Merkmale beim Schwein beeinflussen, 
zu identifizieren. Es wurden insgesamt 310 F2 Schweine aus einer Duroc×Piétrain 
Ressourcen-Population mittels 82 genetischer Marker genotypisiert. Sowohl Vorder- und 
Hinterbeine als auch die Füße der Schweine wurden nach den Deutschen Standardsystem für 
die Lineare Fundamentbeurteilung bewertet. Der Osteochondrose (OC) Status wurde 
histologisch am Kopf und Condylus Medialis des linken Femurs sowie Humerus bewertet. 
Die Merkmale für die Knochenmineraldichte (BMD) wurden an Ulna und Radius mit Hilfe 
der Dual-Röntgen-Absorptiometrie gemessen. Insgesamt wurden 16 QTLs auf 10 Autosomen 
für die Beinschwäche-Merkmale identifiziert. Alle QTLs hatten ein chromosomweites 
Signifikanznivea von 5% bzw. erreichten die QTLs auf SSC2 und 3 für BMD und OC am 
Kopf des Humerus ein genomweites Signifikanz von ebenfalls 5%. Dieses Ergebnis eignet 
sich für weitere Untersuchungen. Gene, die bekannt dafür sind, während der endochondralen 
Ossifikation eine signifikante Rolle zu spielen, wurden als funktionelle beziehungsweise 
positionelle Kandidatengene für diese Studie ausgewählt. Signifikante Assoziationen wurden 
zwischen dem SNP von MMP3 (g.158 C>T) und der OC Gruppe am Femurkopf (P<0,05) 
sowie der BMD Gruppe (P<0,05) in der DuPi Population festgestellt. Die Gelenkknorpel von 
12 Kastraten (6 Kranke und 6 Gesunde, wobei jeweils ein krankes und ein gesundes Tier ein 
Vollgeschwister-Paar bildeten) wurden für die Genexpressionsstudie verwendet. Die Gene 
TGFβ1 und RUNX2 wurden im Vergleich zu gesunden Knorpeln verstärkt in den OC 
(P<0,05) exprimiert. Dagegen war die Expression von MGP bei den OC geringer. Bei der 
Expression von COL2A1, MMP9 und SOX9 konnte kein Unterschied zwischen den beiden 
Gruppen festgestellt werden. Zudem war die Expression des MGP Proteins beim Western 
Blot ebenfalls geringer in der OC Gruppe. Für MGP konnte eine CpG-Region im Promotor 
identifiziert werden. Dabei zeigte sich, dass die DNA-Methylierung von drei CpG 
Bindungsstellen in der OC Gruppe im Vergleich zu der Gruppe mit gesunden Knorpeln höher 
war. Bei der Immunfluoreszenzuntersuchung von normalen Gelenkknorpeln, die von 
Schweinen unterschiedlichen Alters stammten, war das MGP Signal am stärksten bei jungen 
Schweinen und nahm mit zunehmendem Alter ab. Die MGP Proteinexpression war um die 
Knorpel Kanäle am höchsten. Diese Ergebnisse zeigen, dass das MGP Gen ein potentielles 
Kandidatengen für die Entwicklung von OC bei Schweinen sein könnte. Zusammenfassend 
lässt sich sagen, dass die Ergebnisse Informationen zu den QTL Regionen und den 
Kandidatengenen für Beinschwäche-Merkmale beim Schwein liefern. 
  
Genetic analysis and expression study of candidate genes  
affecting leg weakness-related traits in pigs 
 
Leg weakness (LW) problems are a great concern in the pig industry especially with 
regard to animal welfare. The present study was carried out to identify chromosome 
regions and candidate genes affecting LW-related traits in pigs. A total of 310 F2 pigs 
from a Duroc×Pietrain resource population were genotyped using 82 genetic markers. 
Front and rear legs and feet of pigs were scored according to the German standard 
scoring system. Osteochondrosis (OC) was histologically scored at the head and 
condylus medialis of the left femur and humerus. Bone mineral density (BMD) traits 
were measured in the whole ulna and radius bones using dual energy X-ray 
absorptiometry. A total of 16 QTL were identified for LW-related traits on ten porcine 
autosomes. All QTL reached the 5% chromosome-wide significance level. QTL on 
SSC2 and SSC3 for bone mineral content (BMC) and OC at head of humerus, 
respectively, reached the 5% genome-wide significance level which is worthwhile for 
further investigation. Genes known to play significant roles in endochondral ossification 
were selected as functional/positional candidate genes in this study. Significant 
association was found between SNP of MMP3 (g.158 C>T) with OC at head of femur 
(P<0.05) and BMD (P<0.05) in the DuPi population. Articular cartilages from 12 
castrated males (6 were healthy and 6 were diseased, and each healthy and disease pairs 
were full-sibling used for genes expression study. TGFβ1 and RUNX2 genes were 
higher expressed in OC (P<0.05) compared to healthy cartilage. On the other hand, 
MGP was lower expressed in OC but the expression of COL2A1, MMP9 and SOX9 
mRNA abundance was not different. Moreover, the expression of MGP protein was 
lower (P<0.05) in the OC group when quantified by Western blot. One CpG region was 
identified in MGP promoter and DNA methylation of three CpG sites were higher in 
OC compared with normal cartilage. Immunofluorescence of normal articular cartilage 
collected from pigs at different ages revealed that MGP signals were higher in younger 
pigs and decreased in the older pigs. The MGP protein was expressed more near to the 
cartilage canals. These results suggest that the MGP gene might be a potential candidate 
gene for the development of OC in pigs. In summary, the results provided information 
on QTL regions and candidate genes for leg weakness-related traits in pigs. 
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1 Introduction 
Interest in animal welfare continues to increase throughout the world. Health problems 
of the animal affect their well-being and cause considerable economic losses for 
farmers. Leg weakness (LW) is one of the health problems commonly observed in pig 
farms. LW can occur at any age of pigs, but severe signs usually occur in sows and 
boars. Pigs that face LW problem will be culled earlier in the selection process from the 
breeding herd. Therefore, pig breeders are including factors that affect leg soundness 
into their breeding programs. A number of traits can be used to evaluate or predict LW 
in pigs. Leg and feet scores refer to the structure and the overall soundness of both front 
and back of the legs and feet. Furthermore, accumulating data suggest that the primary 
cause of LW in pig is osteochondrosis (OC). OC is a common and clinically important 
joint disorder not only in pigs but also in other domestic animals such as horse, dog and 
chicken. The pathogenesis of OC is still not fully understood and believed to be multi-
factorial, including environmental, nutritional, metabolic and genetics factors. However, 
genetics seem to be the main predisposition factor towards OC. Selecting pig 
considering OC therefore might be helpful to decrease the incidence of leg weakness in 
pigs. Moreover, other determinants or predictors that can be used to estimate the 
fracture risk of the bone and the straightness or the weakness of the legs are bone 
mineral density traits. Low bone density and content can lead to loss of soundness of the 
limb bone.  
The effects of different factors, such as nutrition and management, were elucidated and 
described in addition; genetic is reported to be one of the important factors for LW. 
However, the genetic mechanisms underlying all these leg weakness-related traits are 
complex and not easy to understand. Therefore, studies on the molecular genetic 
mechanisms of traits that cause of leg weakness are important and challenging. So far, 
limited research has been applied to molecular genetic approaches for identifying the 
genes responsible for leg weakness-related traits in pigs. The nature of the genes 
affecting leg weakness-related traits is still largely unknown. Quantitative trait loci 
(QTL) studies for leg weakness-related traits using cross breds between exotic and 
commercial pig breeds are reported. Many candidate genes involved in the pathways 
that regulate chondrocyte behavior during endochondral ossification were identified. 
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However, only a limited number of reports is available confirming the function and the 
association of these candidate genes with leg weakness in pigs. Despite a number of 
factors is known to influence the development of leg weakness or OC specially body 
and leg structure of the animal, growth rate, mechanical stress and body weight. Using 
an intercross between the fast growing breeds such as Duroc and Pietrain could 
considered as a good model for QTL study concerning traits related with leg weakness. 
To gain more knowledge on genes underlying leg weakness-related traits and to identify 
the chromosome region linked with these traits, the present study therefore aimed to:   
1. Localize quantitative trait loci (QTL) influencing leg weakness related traits in 
F2 Duroc × Pietrain resource population.  
2. Identify single nucleotide polymorphisms of positional/functional candidate 
genes and evaluate their association with leg weakness-related traits. 
3. Investigate the expression of candidate genes to detect the potential differences 
expression between healthy and OC cartilage.   
4. Perform the molecular characterization of matrix gla protein gene (MGP) as a 
functional candidate gene for OC in pigs. 
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2  Literature review 
 
2.1 Leg weakness in pigs 
The leg weakness problem has become an important issue in all commercial animals 
including chicken, cattle, goat as well as in pigs. Leg weakness reduces animal well-
being and causes economic losses in all production stages. An evidence to support this 
is that between 20 to 50% of boars completing performance test have to be rejected 
from the breeding herd due to leg weakness problems (Lee et al. 2003, Webb et al. 
1983). Due to the fact that affected animals might not be able to access food and water 
lead to a decrease in productivity and performance. Many factors such as physiological, 
biochemical, nutritional, environmental effects and genetics may be involved in the 
development of leg weakness. Research has highlighted the association between the 
increased incidance of leg weakness and the large improvements in production traits, 
such as high growth rates and carcass composition (Serenius et al. 2004, Stern et al. 
1995). In addition, genetic correlations between leg weakness related traits and 
longivity of breeding sows are reported (Jorgensen 2000, Rothschild et al. 2007).  
 
To date, the genetics underlying or causing leg weakness are still not clear. The 
heritability estimates for leg weakness from sires of Duroc, Landrace, and Yorkshire 
were 0.23, 0.30 and 0.39, respectively (Huang et al. 1995). In Landrace and Large 
White sows, the heritability for overall leg score is estimated to be between 0.27 and 
0.38, respectively (de Sevilla et al. 2009). Duroc pigs were reported to have more 
problems of structure in the front legs than in the rear legs (Goedegebuure et al. 1988). 
Selection of Duroc pigs with different degrees of leg weakness was found to be 
associated with changes in front-leg bone and other factors such as muscle lengths and 
weights (Draper et al. 1992). Despite the potential influence of genetic factor in leg 
weakness, little is known of the genetics of those traits that are directly or indirectly 
associated with leg weakness. Therefore, studies on the genetic basis of these traits will 
be advantageous and may help to select pigs with reduced leg weakness problems.  
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2.2 Feet and leg scores  
Besides body condition score, two of the most important traits used for evaluating feet 
and leg health status of the animals are the feet and leg scores. The scoring is usually 
done by visual evaluation of boars or sows that will be used for breeding proposes. 
Examples of feet and leg evaluation from the National Swine Improvement Federation 
(NSIF) are shown in Figure 1 and 2. Desirable and undesirable feet are indicated in 
Figure 1. The system for evaluating front and rear leg structure is indicated in Figure 2. 
The main propose of evaluating feet and legs is to decrease the contributing factor that 
could lead to defects in locomoting ability. If the animals show bad feet and leg scores, 
this may result in a high number of piglets having leg weakness problems. Therefore, 
leg and feet scores have been considered as common traits in conventional breeding 
approaches. The effect of leg conformation on survivability and performance traits has 
been subjected to intensive research in sows, as it also plays a role in sow longevity (de 
Sevilla et al. 2008, de Sevilla et al. 2009, Serenius et al. 2004). Nevertheless, studies 
related to the genetics of overall or specific feet and leg conformation defects in 
growing and finishing pig are very limited.  
 
  
 
 
 
 
 
 
  
 
 
 
 
Figure 1: Example of feet evaluation in pigs (A) ideal toe size and spacing (B) uneven 
toe size and spacing (C) small foot size (D) cracked hooves. (Adapted from 
the national pork boad) 
 
A B 
C D 
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Figure 2: Example of front and rear leg evaluation in pigs (A) front leg side view (B) 
rear leg side view (Adapted from the national pork board) 
 
 
2.3 Osteochondrosis (OC) 
OC is referred as a cause of leg weakness in pigs (Jorgensen 2000, Stern et al. 1995, 
Ytrehus et al. 2007). It is a common joint disorder found in pig herds. A sample of OC 
lesions is shown in Figure 3. OC leads to economic losses due to culling of pigs at many 
stages of production (Guo et al. 2009, Jørgensen 2000, Kadarmideen et al. 2004). The 
disease occurs with high frequency in growing pigs of all commercial breeds (Jorgensen 
and Nielsen 2005, Lee et al. 2003). The heritability estimates for OC were 0.08 to 0.39 
(Jorgensen 2000), 0.1 to 0.5 (Lundeheim 1987, Stern et al. 1995) and 0.06 to 0.42 
(Kadarmideen et al. 2004) in different breeds. Moreover, OC is also reported to have 
negative effects on important performance traits such as sow longevity, growth and feed 
conversion (de Sevilla et al. 2008, de Sevilla et al. 2009, Kadarmideen et al. 2004, Stern 
et al. 1995).  
A 
B 
Normal rear 
Leg structure 
Post legged 
rear legs 
Sickle hocked 
rear legs 
Soft pasterns 
on the rear legs 
Normal  
front legs 
Soft or weak front 
pasterns 
Buck-kneed front 
legs 
Good OK Cull 
Cull Cull OK Good 
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Figure 3: Osteochondrosis lesions (arrows) in articular cartilage of pigs 
 
The term OC has been previously well described and includes three stages: the 
modifiers latent (lesion confined to epiphyseal cartilage), OC manifesta (lesion 
accompanied by delay in endochondral ossification), and OC dissecans (cleft formation 
through articular cartilage) (Ytrehus et al. 2007). The etiology and pathogenesis of OC 
is not yet clarified. It is characterized by disturbed bone formation, cartilage retention or 
necrosis of the cartilage canal of articular cartilage (Jorgensen 2000, Kadarmideen et al. 
2004). Abnormal vascularisation or the focal failure of blood supply to the growth 
cartilage, leading to a focal disturbance of endochondral ossification, was proposed as 
one of the main causes (Ytrehus et al. 2007). The presence of necrotic areas with 
degenerating vessels in OC cartilage canals also suggests that any defect in cartilage 
canal at focal sites might lead to the disruption of blood supply to the growing cartilage, 
that contribute to OC development (Carlson et al. 1991). The pathogenesis model 
(Figure 4) of OC has been previously descript (Ytrehus et al. 2007). This model 
includes the fragility of cartilage and/or bone, primary dyschondroplasia, necrosis of 
sub-chondral bone and ischemic necrosis of growth cartilage. The authors suggested 
that the primary event in OC is the cessation of cartilage canal blood supply that occurs 
as a result of damage to temporal and newly formed vessels. In addition, the early 
lesions (subclinical) of OC are characterized by areas of chondronecrosis that are also 
closely associated with necrotic, nonperfused vessels in cartilage canals. Nutrition of the 
fetal cartilaginous precursors of the skeleton takes place through cartilage canals 
passing through the cartilage matrix. During the process of endochondral ossification, 
the cartilage canal layer at the articular side becomes thinner to convert into epiphyseal 
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bone and into the final articular cartilage layers in the mature animal (van Weeren 
2006).  
 
 
 
 
Figure 4: Causal diagram showing likely etiologic factors of osteochondrosis and how 
they may influence the development of the disease. The factors playing the 
most important role in primary osteochondrosis are emphasized with bold text 
boxes and solid arrow lines, whereas factors that may play a role in secondary 
osteochondrosis are depicted with dotted arrow lines (Adapted from Ytrehus 
et al. 2007) 
 
 
As OC progresses, structures in the articular cartilage joint are degenerated. Therefore, 
many researchers have focused their studies on molecular mechanisms that are altered 
between normal and degenerated lesion region of articular cartilage. Although articular 
cartilage does not contain blood vessels, prior to the formation of a secondary 
ossification centre, temporary vessel-containing structures, ‘cartilage canals’, are found 
within the growing cartilage, which are involved in the nourishment of the cartilage for 
an appropriate ossification process (Blumer et al. 2004). The typical lesions of articular 
Failure of cartilage canal blood supply 
Ischemic necrosis of chondrocytes 
Osteochondrosis Latens 
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Repair 
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osteochondrosis in pigs were found in the medial aspect and the sagittal ridge of the 
distal condyle of the humerus and the medial condyle of the femur (Ytrehus et al. 2007). 
Jorgensen (2000) stated that OC lesions in the elbow joint have greater influence on 
animal welfare than lesions in the knee joint, and lesions in the elbow joint show the 
highest correlations with clinical leg weakness (Jorgensen 2000). The OC scores in the 
knee joint were found to be higher than in the other joints (Stern et al. 1995). The 
primary changes of this condition were described as early as 2 weeks after birth (Hill et 
al. 1990) but are commonly observed by the time when pigs reached an age of 2 months 
(Ytrehus et al. 2007). However, most of the studies on osteochondrosis in pigs were 
performed as evaluation of lesions in slaughtered  pigs (100-120 kg live weight), thus, 
they described the frequency of manifest lesions (Ytrehus et al. 2004a).  
 
Prevalence of osteochondrosis in purebred Duroc sires and Landrace x Yorkshire sows 
have been reported for Denmark (Jorgensen 2005). It was found that the pathological 
abnormalities on the joint surface of the medial humeral condylus were 38.0% of 9,360 
pigs and 11.7% suffered from osteochondritis dissecans. This result was similar to the 
earlier study in Danish Landrace boars (Jorgensen et al. 1995) and Norwegian Landrace 
x Yorkshire crossbred pigs (Ytrehus et al. 2004). In addition, many researches have 
found a different frequency between sexes for osteochondrosis, in which castrated male 
shows higher OC frequency than female pigs (Kadarmideen et al. 2004, Ytrehus et al. 
2004). However, sex differences for OC are not clarified, since some authors reported 
no difference between castrated male and female pigs (Jorgensen et al. 1995). 
Additional factors that contribute to OC may include external factors such as nutrition 
and management and internal factors such as anatomic characteristics, biomechanical 
influences, trauma, failures of vascularization as well as genetics (Figure 4). As 
mentioned, the exact etiology of OC is not known or not fully understood. However, the 
literature to date provides relatively strong evidence for the roles of genetics and 
anatomic factors. There is compelling evidence that inheritance is important in the 
etiology of OC (Ytrehus et al. 2007), not only in pigs but in other species such as horse 
and dog (Janutta et al. 2006, LaFond et al. 2002, van Grevenhof et al. 2009, Wittwer et 
al. 2007) supporting a heritable component of the disease. 
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2.4 Bone mineral density and content 
Bone mineral status can be used as parameter to assess bone growth, and the risk of 
bone fracture and structural soundness in pigs (Mao et al. 2008, Mitchell et al. 2001). 
The measurement of bone density, reflecting the strength of bones, is represented by the 
calcium content. Bone mineral density (BMD) and bone mineral content (BMC) is 
widely measured by using dual-energy absorptiometry (DXA). This method is suitable 
for examining bone and body composition in longitudinal studies (Grier et al. 1996). 
The accuracy and precision of DXA use in piglets was evaluated, providing more 
information about the use of DXA in subjects with low body mass (Koo et al. 1995). In 
addition, DXA was not only used to measure skeletal mineral status but also to study 
pork carcass composition (Mitchell et al. 1998, Mitchell et al. 2000). Despite the fact 
that several publications in human have demonstrated the association of some candidate 
genes with BMD, there are very few studies on candidate gene or association studies 
dealing with BMD in pigs. Only one publication has been reported on QTL affecting 
BMD of the distal femur in White Duroc × Erhualian intercross (Table 1) (Mao et al. 
2008). Therefore, genes that contribute to variation in susceptibility to low BMD in pig 
remain to be identified.   
  
2.5 Quantitative trait loci (QTL) analysis for leg weakness related traits 
With the advanced developments in molecular genetic analysis during the past few 
decades, QTL experiments in pig have rapidly increased. A well known QTL database 
called PigQTLdb has been developed and has become a valuable tool for pig research 
(Rothschild et al. 2007). Up to date over 5,986 QTL for 581 different traits are reported 
(30 September, 2010). It has helped researchers to share the published data, in particular 
for traits that have low heritability or traits for which measurement of phenotype is 
difficult (Dekkers 2004). Among them, QTL for leg score (Guo et al. 2009b), feet score 
(Lee et al. 2003), OC score (Andersson-Eklund et al. 2000, Christensen et al. 2009) and 
femur BMD (Mao et al. 2008) were identified  in different breeding lines such as White 
Duroc x Erhualian, Wild boar x Large White, Large White x Meishan and Danish 
Duroc x Danish Large White intercrosses (Table 1). A number of factors are known to 
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influence the development of leg weakness or OC, especially body weight, growth rate, 
body and leg structure and mechanical stress of the animal (Jorgensen and Nielsen 
2005). It has been reported that the degree of leg weakness and OC of one sex in a breed 
cannot be translated to the other sex within that breed, nor to the same sex of another 
breed (Van der Wal et al. 1978). This means that the frequency of leg weakness and OC 
varies depending on breed or genetic background of the pigs. Performing QTL studies 
using crossbreds of commercial breeds therefore might provide more insight in to the 
genetics of leg weakness in pigs. Furthermore, identification of QTL for leg weakness 
related traits will help to identify the candidate genes that are possibly associated with 
the development of these traits.  
 
2.6 Candidate genes for leg weakness related traits 
Most of the traits related with health and welfare of the animals are complex, difficult to 
define and are often characterised by low heritability. Thus, applying conventional 
genetics in combination with molecular genetic approaches is of worldwide interest. It 
is well known that there are two approaches for genetic dissections of complex and 
quantitative traits: genome-wide scanning and candidate gene approaches (Zhu and 
Zhao 2007). Candidate genes are generally known as the genes that play an important 
role in directly or indirectly affecting the trait of interest. The candidate gene approach 
has been applied for identifying many genetic diseases both in man and animals 
(Kadarmideen 2008, Kubota et al. 1997, Alexander et al. 2009, Fan et al. 2009). 
Therefore, identification of candidate genes involved in leg weakness related traits 
remains challenging. Focusing on candidate genes that play roles in the biology of bone 
and cartilage development could be of interest to better understand the biological 
background of traits related to leg weakness. However, as mentioned previously, body 
weight, growth rate or body and leg structure of the animal are also considered to be 
main contributing factors.  
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Table 1: QTL for leg weakness-related traits in different pig breeds  
 
Related traits previously 
reported 
Pig chromosome 
(SSC) 
Breed Reference 
Osteochondrosis (femur) 
Femur measurements (weight, 
length, wild) 
5, 3, 15 
17 
European 
wild boars X 
Swedish 
Large White 
Andersson-
Eklund et al. 
2000 
Osteochondrosis 
Front feet scores 
Front leg score 
Back legs scores 
Back feet score 
7 
1, 13, 14 
13, 14 
1, 14 
15 
Large White x 
Meishan pigs 
Lee et al. 2003 
Scapula length  
 
Ulna length  
Humerus length  
Femur length  
Tibia length  
BMD of the distal femur  
1, 2, 3, 4, 5, 7, 13, 
14, 15, X 
1, 4, 5, 7, 13, 14, X 
1, 2, 4, 7, 14, 15, X 
1, 3, 4, 7, 10, 15, X 
1, 7, 13, 15, X 
4, 11,  
White Duroc 
× Erhualian 
intercross 
Mao et al. 2008 
Front leg score at 213 d 
Rear leg score at 213 d 
Gait score of front legs at 153 d 
Gait score of rear legs at 153 d 
Gait score of front legs at 223 d 
Gait score of rear legs at 223 d 
Length of biceps brachii muscle  
Weight of biceps brachii muscle 
1, 2, 3, 4, 7, 13 
2, 4, 5, 7, 13, 16, X 
1, 7, 8 
1, 7, 9 
4, 7, 8, 10 
4, 7 
1, 2, 3, 4, 8, 18, 
1, 2, 4, 7, 8, 10, 15, 
X 
White Duroc 
x Erhualian 
intercross 
Guo et al. 2009 
Osteochondrosis 1, 2, 4, 5, 6, 7, 10, 
13, 15 
Duroc X 
Landrace and 
Large white 
crossbred 
Christensen et 
al. 2009 
Literature review    
 
12 
Therefore, genes involved in animal growth including bone and cartilage as well as 
molecular networks underlying articular cartilage development should also be 
considered. Articular cartilage, also called hyaline cartilage, is an important tissue for 
the passive movement skeletal system. Morphologically, articular cartilage (Figure 5) is 
divided into four layers, having structural and biochemical differences: superficial, 
middle, deep, and calcified. Each zone contains a distinct subpopulation of 
chondrocytes that differs in morphology, distribution within the matrix as well as 
metabolic activity (Simon et al. 2004). During postnatal development, articular cartilage 
undergoes architectural reorganization associated with growth and changes in 
biomechanical demands on the tissue 
 
 
. 
 
 
 
 
 
 
 
 
Figure 5: Histological image of porcine articular cartilage with salfanin-O (A) and 
Masson-Goldner (B) staining (40x) 
 
Chondrogenesis and endochondral ossification are the cartilage differentiation processes 
that lead to skeletal formation and growth in the developing vertebrate as well as 
skeletal repair in the adult (Zuscik et al. 2008). Chondrogenesis (Figure 6) is a process 
for creation of chondrocytes both during embryogenesis as well as in adult life (Zuscik 
et al. 2008). Chondrocyte cells together with the collagen, proteoglycans and non-
collagenous protein are organize into a unique and highly specialized tissue. 
Chondrocytes synthesize all the matrix components and regulate extracellular matrix 
(ECM) metabolism (Bhosale and Richardson 2008). 
A 
B 
 
Superficial 
 
 
Middle 
 
 
 
Deep 
 
 
Calcified 
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Figure 6: Cellular events and molecular markers of chondrogenesis, chondrocyte 
differentiation, and articular cartilage development and maintenance 
(Michael et al. 2008) 
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Endochondral ossification is the process by which the embryonic cartilaginous model of 
most bones contributes to longitudinal growth and is gradually replaced by bone. 
During endochondral ossification, chondrocytes proliferate, undergo hypertrophy and 
die; the cartilage extracellular matrix they construct is then invaded by blood vessels, 
osteoclasts, bone marrow cells and osteoblasts, the last of which depositing bone on 
remnants of cartilage matrix (Mackie et al. 2008). Therefore, candidate genes encoding 
for growth factors, transcription factors and structure molecules involved in 
endochondral ossification are considered in this study. 
 
2.6.1 Transforming growth factor beta 1 
Transforming growth factor beta 1 (TGFβ1), is a multifunctional peptide dimer from a 
family of important regulators of chondrocytes and other cells that controls growth, 
differentiation and other functions (Arevalo-Silva et al. 2001). It has been reported that 
in normal pig epiphyses, TGFβ1 was present in the chondrocytes of the epiphyseal 
hyaline cartilage. This growth factor was found to be deficient in chondrocytes at sites 
of osteochondrosis (Thorp et al. 1995). However, in horse with OC lesions, the 
expression of TGFβ1 was higher, but not significantly in affected tissues (Semevolos et 
al. 2001). This growth factor is therefore thought to be involved in the cascade of events 
associated with chondrocyte function during endochondral ossification. Moreover, 
active TGFβ1 has been reported to play a key role in osteophyte formation (Scharstuhl 
et al. 2002). Taken together, these data suggest that TGFβ1 may play a role in the 
development of OC and that this gene is a candidate for further functional and 
association studies in relation to the incidence of leg weakness or OC in pigs.  
 
2.6.2 Collagen type II alpha 1 and collagen type X alpha 1 (COL2A1 and COL10A1) 
Articular cartilage consist of an extensively cross-linked collagen network. Different 
types of collagen molecules are expressed in articular cartilage. In young cartilage, the 
main type is a copolymer of collagens type II, IX and XI (Figure 7a) (Eyre et al. 2006). 
Once the chondrocyte cells have initiated hypertrophy, the collagen type X is 
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synthesized and is the only known hypertrophic chondrocyte-specific molecular marker 
(Zheng et al. 2003). Possible involvements of type II and X collagen in the development 
of OC are reported. Increases in type II collagen cleavage by collagenases in OCD 
lesions were observed in osteoarthritis (Laverty et al. 2002). Moreover, studies in pig 
have shown that collagen type II was reduced and collagen type X increased in OA 
lesion and near to the lesion samples (Jefferies et al. 2002). Therefore, COL2A1 and 
COL10A1 can be expected to be good candidate genes for OC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Different types of collagen molecules in articular cartilage. (a) Interaction 
model between surface collagen IX molecules and the collagen II polymer 
that can accommodate all the known IX-to-IX and IX-to-II cross-links and 
potential interfibrillar cross-links. (b) Known and speculated sites of peptide 
bond cleavage in the heteropolymer required for degradation and/or lateral 
growth of fibrils (Eyre et al. 2006) 
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2.6.3 Metalloproteinase 3 and 9 (MMP3 and MMP9) 
Proteins of the matrix metalloproteinase family are involved in the breakdown of the 
extracellular matrix in normal physiological processes and disease condition (Kevorkian 
et al. 2004). MMPs are involved in cartilage collagen breakdown (Figure 7b). The 
progression of OC to OA with the degradation of cartilage matrix components is 
generally agreed to be due to an over synthesis and activation of extracellular 
proteinases. MMP3 was significantly decreased in OA but MMP9 was significantly 
increased in OA cartilage (Kevorkian et al. 2004). Several studies in humans have 
measured MMPs in synovial fluid or articular cartilage and reported the differential 
expression of those enzymes in different stages of cartilage disease (Clements et al. 
2009, Davidson et al. 2006, Kevorkian et al. 2004, Yeh et al. 2009). However, the 
molecular mechanisms underlying cartilage destruction are still poorly understood. 
 
2.6.4 Transcription factors sex determining region Y-box9 (SOX9) and runt-related 
transcription factor 2 (RUNX2)  
Two master transcription factors, SOX9 and RUNX2, are involved in skeletal 
development. SOX9 is expressed in all chondrocytes and is essential for the expression 
of the proteoglycan aggrecan, which is secreted by chondrocytes to form the 
characteristic glycosaminoglycan-rich extracellular matrix of cartilage (Tew et al. 
2008). RUNX2 plays important roles in multiple steps of skeletal development. RUNX2 
determines the lineage of osteoblasts from multipotent mesenchymal cells, enhances 
osteoblast differentiation at an early stage and inhibits osteoblast differentiation at a late 
stage (Furuichi and Komori 2004, Komori 2002). Both transcription factors were found 
to be involved in the development of OA. RUNX2 down regulation resulted in reduced 
MMP-13 expression in osteoarthritis chondrocytes. Inhibition of SOX9 increased 
RUNX2 and MMP-13 mRNA expression in normal chondrocytes (Orfanidou et al. 
2009). As previously mentioned, the OA could be the progress from the OC defect. 
Relative expression of both transcription factors might be important in the regulation of 
other genes which play roles in the cellular changes occurring in OC development.   
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 2.6.5 Matrix Gla-protein (MGP)  
MGP is highly accumulated in bone and cartilage and is commonly found at sites of 
calcification in blood vessels (Luo et al. 1997). MGP has been identified as a potential 
calcification inhibitor of extracellular matrix in cartilage and vascular tissue (Eferl et al. 
2004). It contains five vitamin-K-dependent-γ carboxyglutamic acid residues which 
have high affinity to calcium and phosphate ions and can bind to hydroxyapatite crystals 
of mineralized tissue (Coen et al. 2009). MGP-deficient mice have extensive and 
inappropriate calcifications in cartilage and arteries leading to osteopenia (a condition 
where BMD is lower than normal), fractures and blood vessel ruptures (Luo et al. 1997, 
Schurgers et al. 2005) which might be important causes of OC. Abnormalities in the 
human MGP gene have been linked with Keutel syndrome, a condition characterized by 
abnormal calcium deposition in cartilage (Munroe et al. 1999). Genetic variation at the 
human MGP locus was reported to be associated with bone mineral density (BMD) in 
elderly women (Tsukamoto et al. 2000). Moreover, epigenetic change or methylation of 
CpG sites leading to the abnormal expression of specific genes is reported in 
osteoarthritis (Roach and Aigner 2007) in human. Therefore, we hypothesized that 
MGP might be a promising candidate gene for the development of OC in pigs. 
However, to the best of our knowledge, there is no detailed structural and functional 
characterization of the MGP gene and protein in normal and OC cartilage of pigs. 
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3 Materials and methods 
 
3.1 Materials 
3.1.1 Design of the study 
A schematic representation of the overall study design of this study is shown in Figure 
8.  
 
 
Figure 8: Schematic display of the research design used in this study 
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3.1.2 Experimental animals 
3.1.2.1 F2 Duroc × Pietrain (DuPi) resource population  
Samples used in this study consisted of 310 F2 DuPi resource population animals 
including 149 castrated males and 161 females. A more detailed description of this 
population is shown in Table 2. All pigs were kept at the experimental research farm 
‘Frankenforst’ of the University of Bonn and exposed to uniform environmental 
conditions. Piglets were weaned at 28 days of age and placed in collective pens in the 
post-weaning unit until 10 weeks of age. Male piglets were castrated. All animals were 
individually weighed at birth, at weaning, at the beginning and at the end of the testing, 
respectively. Pigs were slaughtered in a slaughterhouse of the research farm 
Schwarzenau in Bavaria. Immediately after slaughter, the left elbow and knee joints 
were separated and the left femur and humerus bones were dissected from the carcass. 
The distal and proximal ends of the femur (head of femur and condylus medialis 
femuris, respectively) and the humerus (head of humerus and condylus medialis humeri, 
respectively) bones were sawn into longitudinal slabs encompassing both the articular 
cartilage and epiphyseal plate or growth plate. In total, 1,240 cartilage samples were 
collected and stored at -20 ºC for histological evaluation and at -80 ºC for gene and 
protein expression studies.  
 
Table 2: Descriptive statistics of performance and carcass traits of the DuPi resource   
               population 
 
Item Means SD Min Max 
Birth weight (kg) 1.49 0.26 0.80 2.40 
ADG (g) 809.75 86.92 581.00 1042.00 
End weight (kg) 109.75 8.76 80.00 133.00 
Slaughter weight (kg) 87.57 7.16 63.50 105.00 
Carcass length   97.89 2.90 87.00 105.00 
Age (day) 185.00 15.56 151.00 230.00 
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3.1.2.1.1 Feet and leg scores 
The animals were evaluated for leg scores in a range from one to five, in which three is 
the optimum level (Table 3). The data were then transformed into a linear scale, by 
using the absolute value of the original scores after subtracting three. Each ‘leg score’ is 
an assessment of the strength of legs, the straightness and the stability of the joints. The 
feet were scored between one and three, where one indicated poor and three indicated 
good. The ‘feet score’ is an assessment of the angle and strength of attachment of the 
feet to the legs and the soundness of the toes and weight distribution on the toes. 
 
3.1.2.1.2 Histology of articular cartilage for osteochondrosis lesion observation 
As OC lesions are often bilaterally symmetrical (Ytrehus et al. 2007), it was decided to 
examine only the left legs of the carcass. The OC was scored on the basis of 
microscopic or histological examination (Figure 9). The recorded OC lesions were score 
from 1 to 4, with 4 = ‘normal’ and 3 to 1 = ‘mildly to severely affected’. Osteochondral 
lesions were observed in the following areas: head of the humerus (HH), condylus 
medialis humeri (CMH), head of the femur (HF) and condylus medialis femoris (CMF). 
The histological assessment was on the basis of the thickness of cartilage, degradation 
of cartilage, and vessels and cartilage canals structure. In brief, the specimens were 
fixed in Bouin's fixative for 48 h, decalcified in RDO (Apex Engineering Products Co., 
Plainfield, IL, USA) and dehydrated through a series of ascending alcohol 
concentrations (70, 80, 90, and 100%, respectively). Subsequently, the sections were 
incubated in Rotihistol (Roth) and embedded in paraffin. Section of 7-10 µm 
thickness were cut and stained following the method of Masson-Goldner. The stained 
sections were examined microscopically at 40x magnification. 
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Table 3: Scoring criteria for legs and feet scores 
 
Traits Attribute Scores 
 5 4 3 2 1 
Strength of legs Poor Moderate Very good Moderate Poor 
Straightness Flexing Slightly 
bent 
Straight Buckled Very buckled Legs 
  
 
Scores 
   3 2 1 
Toes-soundness   Good Moderate Poor 
Toes-weight distribution   Even Moderate Uneven 
Angle of foot attachment   Good  Moderate  Low  
Feet 
Damage   None Slight or 
temporary 
Permanent 
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Figure 9: Sample of histological templates for the evaluation of OC score. OC lesions 
are classified into 4 scores; (1) massive alterations of the cartilage including 
necrotic or ossified areas and also when cartilage becomes bony, (2) severe 
changes in the surface and deeper area of the articular cartilage like surface 
erosion, fibrillations, hyperplasia and chondrocyte necrosis, (3) cartilage 
surface consists of few changes in surface and fibrillation, (4) cartilage surface 
is smooth, the matrix and chondrocytes are well organized or only marginally 
rough surface or weakly eosinophilic matrix or fibrillation are observed. 
 
3.1.2.1.3 Bone mineral density traits 
The whole ulna and radius bones from the left carcass were stripped of all surrounding 
tissues. The samples were sent to the testing and educational farm Oberschleißheim of 
the Ludwig-Maximilians-University of Munich to be examined using X-ray. BMD, 
BMC and BMA were observed by a dual-energy X-ray absorptiometry (DXA). 
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3.1.2.2 Animal for association analysis  
Data from 299 pigs with OC were supplied from the SUISAG Company. The pigs were 
the station-tested animals and were crossbreeds by using Large White × Landrace as 
dam lines and Large White × Duroc as sire lines. Further description of the animals and 
the scoring criteria are given in the report of Kadarmideen et al. (2004). The data 
include OC scores at seven different joint areas: head of humerus (HH), condylus 
medialis humeri (CMH), condylus lateral humeri (CLH), radius/ulna proximal (RAD), 
distal epiphysis ulna (DEU), head of femur (HF) and condylus medialis femoris (CMF). 
A summary of the OC phenotype distribution of the animals is shown in Table 4.   
 
Table 4: Number and percentage of osteochondrosis scores at different joints of the 
commercial population 
Trait (n=299) Number of joints (%) 
OC score 6 5 4 3 2 1 
HH  
 
 0 
 
 0 
 
1  
(0.33) 
2  
(0.67) 
0 
 
296  
(99) 
CMH  
 
 0 
 
0 
  
 0 
 
28  
(9.63) 
31 
(10.37) 
240 
(80.27) 
CLH  
 
 0 
 
 0 
 
1  
(0.33) 
3  
(1) 
4  
(1.34) 
291 
(97.32) 
RAD  
 
0 
  
 0 
 
0 
  
0 
  
25  
(8.36) 
274 
(91.64) 
DEU  
 
2  
(0.67) 
70 
(23.41) 
47 
(15.72)  
15  
(5.02) 
134 
(44.82) 31 (10.37) 
HF  
 
 0 
 
0 
  
0 
  
0 
  1 (0.33) 
298 
(99.67) 
CMF  
 
0 
  
 0 
 
2  
(0.67) 
21  
(7.02) 
87 
(29.10) 
189 
(63.21) 
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3.1.3 Chemicals and equipments 
3.1.3.1 Chemicals and kits 
Amersham Biosciences (Freiburg): GFXTM PCR DNA and gel band purification kit 
Applied Biosystems (Foster City): SYBR® Green universal PCR master mix 
BD Biosciences Clontech (USA): SMARTerTM RACE cDNA amplification kit 
Beckman Coulter (Krefeld): CEQ™ 8000 genetic analysis system, dye terminator cycle 
wequencing (DTCS), glycogen  
Biomol (Hamburg): phenol, phenol/chlorophormllsoamyl alcohol (25:24:1). 
Invitrogen Life Technologies (Karlsruhe): DTT, random primers 
MBI Fermentas (St. Leon-Rot): glycogen 
Promega (Mannheim): BSA, pGEM®-T vector, RQ1 RNase-free Dnase, RNasin 
ribonuclease inhibitor, 2X rapid ligation buffer, T4 DNA ligase, E.coli strain 
JM109 
Qiagen (Hilden): RNeasy® mini kit, QIAquick PCR purification kit, mini eluteTM 
reaction cleanupkit 
Roth (Karlsruhe): acetic acid, agar-agar, ampicillin, bromophenol blue, dimethyl 
sulfoxide (DMSO), ethylenediaminetetraacetic acid (EDTA), ethanol, 
ethidium bromide, hydrochloric acid, isopropyl-D-thiogalactoside (IPTG), 
peptone, potassium dihydrogen phosphate, 2-propanol, sodium acetate, sodium 
carbonate, sodium chioride, sodium hydroxide, trichloromethane/chiorophorm, 
tris, x-gal(5-bromo-4-chloro-3-indolylbeta-D-galactopyranoside), yeast extract 
Sigma-Aldrich Chemie GmbH (Munich): agarose, ammonium acetate, calcium chloride, 
formaldehyde, genEluteTM plasmid miniprep kit, glutamine, hepes, 
isopropanol, magnesium chloride, 2-Mercaptoethanol, penicillin, phenol red 
solution, 10X PCR reaction buffer, potassium chloride, sodium dodecyl sulfate 
(SDS),  
Stratagene (Amsterdam): 5 c DH Escherichia coli competent cells 
USB (Ohio): ExoSAP-IT 
Zymo Research: DNA methylation bisulfite assay kit 
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3.1.3.2 Reagents 
All solutions were prepared with double deionised water. 
10X TBE  
Tris borate, pH 8.0   90  mM 
EDTA, pH 8.0    20  mM 
Water added to   1000  mL 
 
10X TE   
1 M Tris pH 8.0    50  mL 
0.5M EDTA pH 8    0.5  mL 
ddH2O     445  mL 
Autoclave to sterilize (121 oC for 30 min) 
 
10X PBS 
 NaCl     87.76 g 
 Na2HPO4.2H2O   15.00 g 
 NaH2PO4    2.04  g 
 Water added to   1000 mL 
 
1X PBS-Tween (PBST) 
 1X PBS    999.50 mL 
 Tween®20    0.5 mL 
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4X Sample loading buffer 
 Tris (1 M, pH 6.8)   13.00 mL 
 SDS     6.00 g 
 2-Mercaptoethanol   10.00 mL 
 Glycerine    20.00 mL 
 Bromophenol blue   10.00  mg 
 Water added to   50.00 mL 
 
50X TAE   
Tris base    242  g 
Glacial acetic acid   57.1  mL 
0.5 M EDTA pH 8.0   100  mL 
Water added to   1000  mL 
 
Agarose gel loading buffer: 
Bromophenol blue   0.25 % 
Xylene cyanol    0.25 % 
EDTA     120  mM 
 
Ampicillin (10 mg/ml): 
Ampicillin powder    2  g 
Sterile, distilled water,   40  mL 
Filtrate with 0.45 µl filter 
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Blue dextran loading buffer: 
 Blue dextran     50  mg 
 EDTA (0.5M)    50  µl 
 Water      950  µl 
 Formamide    5  mL 
 
DEPC-treated water: 
 DEPC     1 mL/L water 
 Incubation at 37 oC for overnight and heat inactivated by autoclaving  
  
Digestion buffer 
 9%NaCl    6.50 mL 
 Tris (1M, pH 7.5)   5.0 mL 
 EDTA (0.5 M, pH 8.0)  0.20 mL 
 SDS (10%)    1.00 mL 
 Mercaptoethanol   2.00 mL 
 
Proteinase K :    10 mg/mL 
 
X-Gal (50 mg/ml) : 
X-Gal      50 mg  
N, N-dimethylformamide  1 mL 
 Stored at -20 oC 
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3.1.3.3 Media 
LB-agar plate 
Sodium chloride   8.0 g 
 Peptone    8.0 g 
Yeast extracts    4.0 g 
Agar-Agar    12.0 g 
Sodium hydroxide (40.0 mg/ml) 480 µl 
Water added to   800 mL 
 Autoclave (121 oC for 30 min) 
 
LB-broth 
 Sodium chloride   8.0 g 
 Peptone    8.0 g 
Yeast extracts    4.0 g 
Sodium hydroxide (40.0 mg/ml) 480 µl 
Water added to   800 mL 
Autoclave (121 oC for 30 min) 
 
3.1.3.4 Enzymes 
SuperScriptTM II Rnase H-Reverse Transcriptase (Gibco BRL, Karlsruhe), 
(Invitrogen Life Technologies, Karlsruhe) 
Pfu DNA polymerase (Promega) 
Taq DNA polymerase (Sigma) 
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3.1.3.5 Equipments 
Apotome microscope  
Carl Zeiss  
Centrifugation 
HERMLE Z 323K, Wehingen 
Electrophoresis/DNA Analyzer: Automated sequencer 
LI-COR, DNA Analyzer, GENE READER 4200 (MWG-BIOTECH) 
Electrophoresis system 
 For agarose gel: BioRad, Göttingen 
 Vertical apparatus: Consort, Turnhout 
 Power supply: PAC 3000 BioRad 
Thermocycler: 
 PTC-100 Programmable Thermal Controller (MJ Research, Inc. USA) 
 
3.1.3.6 Software used  
CRIMAP Version 2.4 (Green et al. 1990) 
Image Analysis (version 4.10) LI-COR Biotechnology, USA 
SAS version 9.02 SAS Institute Inc., Cary, NC 
BLAST program: http://www.ncbi.nlm.nih.gov/blast/ 
DNA to protein translate tool: http://us.expasy.org/tools/dna.html 
MapChart2.2: http://www.biometris.nl/uk/Software/MapChart/ 
Multiple Sequence Alignment: 
http://saturn.med.nyu.edu/searching/promultali.html 
QTL-express http://qtl.cap.ed.ac.uk/ 
Restriction enzyme analysis : http://tools.neb.com/NEBcutter/index.php3 
Primer design: http://www-genome.wi.mit.edu/cgibin/primer/primer3_www.cgi 
BiQ Analyzer: http://biq-analyzer.bioinf.mpi-sb.mpg.de/ 
CpGProd software: http://pbil.univ-lyon1.fr/software/cpgprod_query.html 
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Image-J software: http://rsbweb.nih.gov/ij/ 
Multiple Sequence Alignment: http://pbil.ibcp.fr/htm/index.php  
QUMA: http://quma.cdb.riken.jp/  
TSSP: http://www.softberry.ru 
 
 
 
3.2    Methods 
3.2.1 DNA isolation from cartilage and muscle tissues 
For genotyping, genomic DNA was isolated from tail samples using the standard phenol 
chloroform method. Samples of about 1 g were cut into small pieces and were digested 
by proteinase K (10 mg/ml). The digestion buffer included 700 µl of digestion buffer, 
70 µl of 10% SDS. Samples were incubated overnight at 37 °C. Seven hundred µl of 
phenol-chloroform were added and then the tube was shaken until an emulsion was 
formed and centrifuged at 10,000 rpm for 10 min. The upper part was transferred into a 
2 ml tube, 700 µl of chloroform were added and shook gently. Samples were 
centrifuged at 10,000 rpm for 10 min. The upper part was carefully collected into 1.7 ml 
tube, 700 µl of isopropanol and 70 µl of 3M sodium acetate were added into the tube 
and the samples were shaken gently until precipitation of DNA and then centrifuged at 
10,000 rpm for 5 min. The aqueous phase was discarded, then 200 µl of 70% ethanol 
were added, the pellet liberated from the tube surface then centrifuged at 10,000 rpm for 
5 min. The aqueous phase was discarded and the pellet was left to dry. Five hundred 
microlitres of 1X TE were added and the DNA samples left overnight at room 
temperature. The DNA concentration were measured and diluted to a concentration of 
50 ng/µl. For DNA methylation analysis, genomic DNA was isolated from articular 
cartilage using Tri reagent according to the manufacturers’ protocol.  
 
3.2.2 DNA isolation from agarose gel 
The band of interest was excised with a sterile razor blade, placed in a microcentrifuge 
tube, frozen at –20 oC for at least 1 hour. The band was chopped and 500 µl TE buffer 
were added. The gel was homogenized by repeated pipeting using a syringe attached 
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with a needle. Five hundred microlitres of phenol-chloroform (1:1) was added to the 
DNA solution and vigorously vortexed for a few seconds to form an emulsion. After 
centrifugation at 12,000 g for 15 min the upper aqueous layer was carefully removed to 
a new tube. An equal volume of chloroform was added to the aqueous phase, vortexed 
and centrifuged for 15 min at 12,000 g to allow phase separation. The aqueous layer 
was transferred to a new tube. One-tenth volume of 3M sodium acetate (pH 5) and two 
volumes of cold 100% ethanol were added to the DNA sample in a microcentrifuge tube 
and mixed by inversion. This precipitation was performed by incubation at –20 oC 
overnight or at –80 oC for at least 30 min. To recover the precipitated DNA, the mix 
was centrifuged at 12,000 g in a microcentrifuge for 20 min at 4 oC. After the  
supernatant was discarded, the DNA pellet was washed with a cold 75% ethanol 
(corresponding to about two volume of the original sample) being first incubated at 
room temperature for 5-10 min and centrifuged again for 5 min. The supernatant was 
drained being inverted on a paper towel until the DNA pellet was air dried. Finally, the 
DNA pellet was dissolved with 5 µl of distilled H2O. 
 
3.2.3 RNA extraction from articular cartilage 
Articular cartilage samples were used for RNA isolation. Frozen tissue samples (1 to 10 
mg) were powdered by mortar and pestle, 1 ml of TRIZOL reagent was added and 
homogenised. The homogenised samples were incubated for 5 min at room temperature. 
Then 0.2 ml of chloroform were added to homogenised samples, mixed thoroughly by 
shaking and incubated for 15 min at room temperature. Samples were centrifuged at 
12,000 g for 15 min at 2 to 8 °C. The RNA remains exclusively in the upper aqueous 
phase which was transferred to a fresh tube. The RNA in the aqueous phase was 
precipitated by adding 0.5 ml of ethanol. The samples were incubated at room 
temperature for 10 min and centrifuged at 12,000 g for 10 min at 2 to 8 °C. The 
supernatant was removed and the RNA pellet was washed once with 1 ml of 75% 
ethanol. After centrifugation and removal of supernatant, the RNA pellet was air dried 
and dissolved in 50 µl RNase-free water and stored at –80 °C for further use. The RNA 
was treated with DNase to remove residual DNA. The DNA digestion was performed 
by mixing, the following components in a 0.5 ml RNase free tube: 25 µl RNA, 5 µl 10X 
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buffer, 2 µl RQ1 RNase-Free DNase, 1 µl RNase inhibitor (40 U/µl), and 17 µl RNase-
free water and incubated at 37 °C for 1 hour. After incubation, the RNA was purified by 
RNeasy Mini Kit (Qiagen). To assess the quality of RNA, 2 µl RNA sample was 
electrophoresed on 1.2% agarose gel.  
 
3.2.4 cDNA synthesis  
The total RNA was used to synthesize first strand cDNA. The reaction was performed 
in a nuclease-free microcentrifuge tube, 1 µl oligo dT(11) (500 µg/ml), 1 to 5 ng total 
RNA, 1 µl 10 mM dNTP mix and 12 µl sterile water were added in a 0.2 ml PCR tube. 
The mixture was heated at 70 °C for 10 min and immediately chilled on ice. The 
contents of the tube were collected in bottom by brief centrifugation and 4 µl 5 X first-
strand Buffer (Gibco BRL, Karlsruhe Germany), 2 µl 0.1 M DTT and 1 µl RNase OUT 
Recominant Ribonuclease Inhibitor (40 U/µl) were added. The reaction was gently 
mixed and incubated at 40 °C for 2 min. One microlitre (200 units) of SuperscriptTM II 
RNase H reverse transcriptase was added and further incubated at 42 °C for 90 min. The 
reaction was inactivated by heating at 70 °C for 15 min. The cDNA was diluted 1:4 in 
RNase free water and was used as a template for subsequent PCR amplifications. The 
cDNA samples were stored at -20 oC for further use. 
 
3.2.5 Amplification of 3' and 5' ends of MGP by RACE PCR 
Total RNA from cartilage was used for 3' and 5' RACE (Rapid Amplification of cDNA 
Ends) using the SMARTer™ RACE cDNA Amplification Kit (Clontech). First-strand 
cDNA synthesis was performed, and then 3' and 5' RACE-PCR were individually 
performed using the universal primers and the gene specific primers (GSP). The PCR 
was performed using the following conditions: 35 cycles of 94 °C for 30 s, 60 °C for 
30s and 72 °C for 2 min. The PCR products were sequenced after gel purification and 
cloning. 
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3.3.6 PCR conditions 
PCR amplification was performed in 20 µl reaction volume using 25 ng of genomic 
DNA, 0.2 µM of each primer, 50 µM of each dNTP, 0.5 U of Taq polymerase in 10X 
PCR reaction buffer supplied with 1.5 mM MgCl2. Thermocyling was performed using 
the following program: initial denaturation for 5 min at 95 °C, 35 cycles of each 30 sec 
at 95 °C, 30 sec at annealing temperature fore each primer, and 30 sec at 72 °C, 
followed by 10 min final extension at 72 °C. 
 
3.2.7 Protein extraction from articular cartilage  
 The same articular cartilage tissues used for RNA extraction were also used for protein 
extraction. Proteins were isolated from the phenol-ethanol supernatant obtained after 
precipitation of DNA with ethanol. Three volumes of acetone were added to the 
supernatant, mixed by inversion and incubated for 10 min at room temperature. After 
protein precipitation at 12,000 g for 10 min at 4 ºC, protein pellets were washed by 0.5 
ml of protein wash (0.3 M guanidine hydrochloride in 95% ethanol and 2.5% glycerol). 
After dispersing the pellet, an additional 3 time wash with 1 ml of protein wash were 
added, incubated for 10 min at room temperature and sedimented by centrifugation at 
8,000 g for 5 min. The final wash was performed in 1 ml of ethanol containing 2.5% 
glycerol (V:V). Protein pellets were dried for 5-10 min at room temperature and 200 µl 
of digestion solvent were added to solubilise the pellet and stored at -20 °C for further 
use. 
 
3.2.8 Ligation and transformation 
The purified PCR fragment was ligated into a pGEM-T easy vector (Promega, 
Mannheim Germany). The reaction was performed in 5 µl total volume, which 
contained 2.5 µl 2 X ligation buffer, 0.5 µl pGEM–T Vector, 1.5 µl PCR products and 
0.5 µl T 4 DNA ligase. The reaction was gently mixed and incubated for 1 hour at room 
temperature or at 4 °C overnight. For transformation, competent E.coli DH5α were 
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aliquoted to chilled polypropylene tubes and 3 µl of ligation reaction mix were added by 
60 µl of the competent cells. The mixture was incubated on ice for 30 min. The cells 
were then heat shocked at 42 oC for 90 sec, incubated on ice for 2 min, and 700 µl LB 
medium were added at room temperature. The culture was incubated at 37 oC in a 
shaking incubator for 90 min. For each ligation reaction, two LB plates supplemented 
with ampicillin (100 µg/µl) were prepared by adding 0.10 M IPTG and 20 µl of X-Gal 
and spreaded with a glass pipette being allowed to absorb for 20 min prior to use. The 
transformed bacterial culture was plated in duplicate and the plates were incubated at 37 
oC overnight. Successful cloning of the insert will produce white colonies as it 
interrupts the coding of ß-galactosidase. The presence of the DNA insert in white 
colonies was confirmed by M13 PCR.  
 
3.2.9 Sequencing  
PCR products were purified using EXO-SAP IT. Five microlitres of purified sample 
were used for cycle sequencing, with specific primers and the Quick Start Kit for Dye 
Terminator Cycle Sequencing or DTCS (BeckmanCoulter, Krefeld, Germany), 
including DNA polymerase, pyrophosphatase, buffer, dNTPs and dye terminators. Once 
the sequencing-PCR was performed, 3M NaOAc, 100 mM EDTA and glycogen were 
added to stop the reaction. To each sample, 60 µl of 98% ethanol (Roth) were added and 
mixed well by vortexing and then centrifuged for 15 min at 18,000 rpm at 4 °C. All 
liquid was removed and replaced with 200 µl 70% ethanol without mixing and 
centrifuged again for 15 min at 18,000 rpm at 4 °C. The ethanol was then removed and 
the sample was air dried for 10 min. The sample was then resuspended in 40 µl of 
sample loading solution (SLS) (Beckman Coulter). Cleaned up samples were transferred 
manually to a CEQ sample plate and overlaid with mineral oil. Samples were sequenced 
using the CEQ™ 8000 Genetic Analysis System (Beckman Coulter). 
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3.2.10 Genomic bisulfite PCR and sequencing 
Genomic DNA was extracted from 9 OC and 9 healthy articular cartilages, the same 
samples as used for gene expression analysis. Each DNA (1 µg) was modified with the 
bisulfite conversion reaction according to the manufacturer protocol (EZ DNA 
Methylation Kit, Zymo Research). The converted DNA was diluted with 15 µl of 
ddH2O. Each converted DNA (2 µl) was used as a template for PCR with primers 
designed using the MethPrimer program (Li and Dahiya 2002). The PCR products 
amplified from the bisulfite-treated DNA were further analyzed through cloning and 
sequencing. Each of the PCR products was purified using QIAquick PCR purification 
kit (Qiagen), and then individually cloned into the pGEM-T Easy vector (Promega). A 
minimum of 5 different clones were randomly selected for sequencing with M13 
primers. Methylation sites were visualized and quality controlled by using BiQ 
Analyzer (Bock et al. 2005) and QUMA (Kumaki et al. 2008) software.    
 
3.2.11 Screening for polymorphic sites 
In silico analysis by comparing several sequences from the database revealed the 
possible targets for PCR amplification. The SNP positions were confirmed by 
comparative sequencing of PCR fragments in a SNP discovery panel of F2 animals from 
DuPi. The screening primers used in this study are shown in Table 5.   
 
3.2.12 Genotyping 
SNPs were genotyped depending on the suitability of the mutation and the surrounding 
sequences to design a PCR-RFLP. COL2A1, COL10A1, MMP3 and TGFβ1 were 
genotyped by PCR-RFLP analysis (restriction enzyme and size of the PCR product are 
shown in Table 6 and Figure 10).   
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Table 5: List of primer names, sequences and their applications in this study 
Primer name  Sequence (5´- 3´) Purpose 
MGPBi F TTAATTGGTTAGGATTAAGAGGTTATTTTT Methylation  
MGPBi R CCACAACCATATAACAATACCAAATC Methylation 
MGPRTPCR F GTGGCAGCCCTGTGCTAT Real time PCR 
MGPRTPCR R GGAGGCTTGTTGAGTTCTCG Real time PCR 
MGPG2-F  F GCAGAGATGGAGAGCGAAAG PCR for 3’ RACE 
MGPG2-R  R GCAAGCTTCCCGGTTTAACT PCR for 5’ RACE 
MGPG1-F  F TCACAAACACTCAATGCCTGA Genomic sequencing 
MGPG1-R  R TTTCCCAAAGGAGACCCTCT Genomic sequencing 
MGP.W-F1 F CTGGAGCCAGTGGTTTCTGT Genomic sequencing 
MGP.W-R1 R TCTGTGTGGTTGATGTGGTG Genomic sequencing 
MGP.W-F2 F  TTGTGTCGGAGAGTATTCATGG Genomic sequencing 
MGP (F2) F GCCATGGTTTATGGATACAAC Genomic sequencing 
MGP (R1) R AAATAACGATTGTAGGCGGCA Genomic sequencing 
MGPexon1R R AGGAGCAGGCTCTTCATGGT Genomic sequencing 
MGPexon2R  R GCTTTCGCTCTCCATCTCTG Genomic sequencing 
MGPexon3R  R GGAGGCTTGTTGAGTTCTC Genomic sequencing 
MGPintron1F F CCAGGGAGAGGACTGTCTCA Genomic sequencing 
MGPintron3F F AGACTCCAGTGGCTGGTTTG Genomic sequencing 
MGPfr185 :  F GCCACAGCAGAGATGGAGA Genomic sequencing 
MGPrv240 :  R TTCATAGGATTCCAAGCTCTCA Genomic sequencing 
MGPfr18 F AGACCCTGAGAGCAACCTCA Genomic sequencing 
MGPrv529  R CCATGGCACTTTCATTCCTT  Genomic sequencing 
MGP152f  F GTGGCAGCCCTGTGCTAT Genomic sequencing 
MGP152r  R GGAGGCTTGTTGAGTTCTCG Genomic sequencing 
GAPDH F ACCCAGAAGACTGTGGATGG Real time PCR 
GAPDH R ACGCCTGCTTCACCACCTTC Real time PCR 
TBP F GATGGACGTTCGGTTTAGG Real time PCR 
TBP R AGCAGCACAGTACGAGCAA Real time PCR 
TGFβ1 F CCACTCTCAGCCTCTCTGCT                           Real time PCR 
TGFβ1 R TGGGTTCTCGGTATCCTACG Real time PCR 
MMP9 F GTCCTGGTGCTCCTGGTG Real time PCR 
MMP9 R AACCCTCATTAGCCCATTCC Real time PCR 
SOX9 F CTCAAGGGCTACGACTGGAC Real time PCR 
SOX9 R GAGTTTGCCCAGAGTCTTGC Real time PCR 
COL2A1 F AAGGTGGGAAACCAGGTGAT Real time PCR 
COL2A1 R AGGAGCTCCAGCTTCACCAG Real time PCR 
RUNX2 F CAGACCAGCAGCACTCCATA Real time PCR 
RUNX2 R ACGCCATCATTCTGGTTAGG Real time PCR 
M13 F TTGTAAAACGACGGCCAGT PCR and Seq 
M13 R CAGGAAACAGCTATGACC PCR and Seq 
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Table 6: List of primers and enzymes used for PCR-RFLP analysis 
Gene Primer (5′-3′) 
Product 
size 
SNP 
Position 
Enzyme 
F1:CAAAGATGGCGAGACAGGTG 
COL2A1 
R1: CAGATGGCCCAGGAGCAC 
397 Intron 29 MspI 
F4:TTCAGCCTACCTCCATATGCAT 
COL10A1 
R4:CAACAGCACTACGACCC 
400 3’UTR TaqI 
F1:GACGGGAAAGCTGGATTCTA 
MMP3 
R1:CCAGGTGCATAGGCATGAG 
429 Intron 2 DdeI 
F1:CTACTCATCCATCTGAGTG 
TGFβ1 
R1:GAAGCAGTAGTTGGTATCCA 
932 Intron 6 BseYI 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Sample of PCR-RFLP for genotyping (A) COL2A1, (B) MMP3genes 
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3.2.13 Marker data for QTL analysis  
Marker genotyping data from SQL-based database at the Institute of Animal Science, 
University of Bonn, Germany were used in this study. A linkage map with the total 
length of 2588.7 cM and an average marker interval of 31.57 cM was used. P, F1 and F2 
animals of the DuPi population were genotyped with 82 genetic markers to cover all 
porcine autosomes. The set of markers includes 79 microsatellites and 3 biallelic 
markers. The order of markers and the genetic distances between them have been 
described (Uddin et al. 2010). These markers were mainly selected from the 
USDA/MARC map (http://www.marc.usda.gov). In brief, DNA was isolated from tail 
muscle samples using the phenol-chloroform clean up and the salt precipitation. DNA 
was dissolved and kept at 4 °C. Different single and multiplex PCR were applied to 
amplify the fragments. All PCR reactions were performed using a thermocycler PTC 
100 (MJ Research USA). Genotyping, electrophoresis, and allele determination were 
done using a LI-COR 4200 Automated Sequencer (DNA Analyzer, GENE Reader 
4200). The fragment analysis was performed using the OneDScan program 
(Scanalytics) to identify the length of the different amplified alleles. Allele and 
genotyping errors were checked using Pedcheck software (v 1.1).  
 
3.2.14 Western blot 
The proteins extracted from 3 OC and 3 healthy cartilages from condylus medialis 
humerus of 3 full-sib pairs were separated by SDS-PAGE (gradient 8-18%). 
Subsequently the proteins were transferred onto a nitrocellulose membrane (Protran®, 
Schleicher & Schuell Bioscience). After blocking in blocking buffer (20 mM Tris pH 
7.5, 150 mM NaCl, 0.05% Tween-20 and 1% polyvinylpyrolidone) at room temperature 
for 1 h, the membrane was incubated with the polyclonal anti-MGP antibody purified 
from goat (Cat.Sc32820; Santa Cruz). The horseradish peroxidase-conjugated donkey 
anti-goat IgG (Cat.Sc2020; Santa Cruz) was used as the secondary antibody. The 
chemiluminescence was detected by using the ECL plus Western blotting detection 
system (Amersham Biosciences) and visualized by using Kodak BioMax XAR film 
(Kodak). GAPDH was used as a loading control and for normalizing. The membrane 
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was stripped by incubation in 2% SDS, 100 mM Tris–HCl, 0.1% beta-mercaptoethanol 
for 30 min at 60 °C and re-probed with goat polyclonal GAPDH antibody 
(Cat.Sc20357; Santa Cruz). Relative band intensities were compared by determining the 
ratio of the area densities of MGP to GAPDH bands for each lane using Image-J 
software (National Institute of Mental Health, Bethesda, Maryland, USA).  
 
3.2.15 Immunofluorescence 
Expression of the MGP protein was detected by immunofluoresence at three different 
ages of healthy animals. Due to the limitation of fresh sample availability for OC 
cartilage, we localized the MGP protein in cartilages collected from one day, 2 months 
and 6 months old healthy pigs. The animals used in this study were three half siblings 
(all are males, the 2 months and 6 months old were castrated) of the Duroc and Pietrain 
cross breeds that were born and raised in the same herd and under similar standard 
conditions. Immediately after collection, tissues were fixed in 4% paraformaldehyde for 
24 h and cryoprotected with Tissue-tek (Sakura, Netherlands) and cut using a 
cryotome. All sections were kept in -80 ºC for further analysis. Cartilage cryosections 
(8-12 µm-thick) were fixed for 15 min in freshly prepared 4% paraformaldehyde. 
Sections were washed in PBS and blocked for 1 h in PBS with 0.3% donkey serum 
followed by incubation for 90 min at 37 ºC with goat polyclonal anti-MGP (Cat.sc-
32820, Santa Cruz) primary antibody (diluted 1:100 in PBS containing 0.3% goat 
serum). After three washes in PBS, the sections were blocked for 30 min with PBS 
containing 0.3% normal goat serum. The sections were then incubated for 1 h at room 
temperature with secondary donkey anti-goat antibody conjugated with fluorescein 
isothiocyante (FITC) (Cat.sc-2024, Santa Cruz). After several washes in PBS, the 
sections were mounted in Vectashield (Vector Laboratories) containing 40,6-diamidino-
2-phenyl indole (DAPI). For negative controls, the primary antibody was substituted by 
PBS. Images were obtained by an apotome microscope (Carl Zeiss, Germany). 
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3.2.16 Promoter prediction and CpG island identification for the porcine MGP gene 
The web based Primer3 (Rozen and Skaletsky 2000) program was used for designing 
primers (Table 5). Genomic DNA was amplified by PCR and sequencing of amplified 
PCR fragments was performed by the CEQ8000 sequencer system (Beckman Coulter). 
A sequence of transcription start site (TSS) was predicted using the TSSP program. The 
published sequences (NC_010447) of the 5´-flanking regions which contained the 
promoters of the MGP gene were submitted to the CpGProd software (Ponger and 
Mouchiroud 2002) in order to identify the CpG islands.  
 
3.3 Statistical analysis  
Relative means of gene expressions were compared between normal and OC groups by 
the student t-test. The data were analyzed using the software package SAS (v 9.2, SAS 
Inc., CA, USA) for a detailed description of the data structure. Generalized linear 
models (PROC GLM) were used to identify any possible obvious effect of sire, dam, 
age, sex, birth weight, daily weight gain, litter size, parity, season, slaughter weight and 
carcass length on the investigated traits.  
 
3.3.1 QTL mapping  
F2 QTL interval mapping was performed using the web-based program QTL Express 
(Seaton et al. 2002) available at http://qtl.cap.ed.ac.uk/ based on a least square method. 
The analyses were carried out at chromosome and genome wide level with a single QTL 
model. The basic QTL regression model used in the present study was: 
yi = µ + Fi + Cj + caia + cdid + ei 
 
where:  
yi = phenotype of the ith offspring;  
µ = overall mean;  
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Fi = fixed effect of parity; 
Cj= regression coefficient on the covariate; covariate (average daily gain for leg and feet 
score; age for OC; slaughter weight and carcass length for DXA);  
cai = additive coefficient of the ith individual at a putative QTL in the genome;  
cdi = dominant coefficient of the ith individual at a putative QTL in the genome;  
a = additive effects of a putative QTL;  
d = dominant effects of a putative QTL; and 
ei = residual error 
 
 
The regression model was fitted at 1-cM intervals along each chromosome and the F-
value for the QTL effect was calculated at each point. Significance thresholds were 
determined by data permutation (Churchill and Doerge 1994) at 1000 iterations. The 
chromosome-wide significance level was used as the suggestive significance level 
(Ding et al. 2009) and ranged from 3.8 to 5.2 for different chromosomes. The empirical 
95% confidence intervals (CI) and flanking markers for the QTL positions were 
obtained by applying the bootstrapping approach with 1000 re-sampling.  With two 
linked QTL, the 95% CI for each was determined by fitting one of them as a cofactor 
for the other. The phenotype variation that was explained by a QTL was calculated by 
the following equation. 
 
100% ×−=
R
FR
MS
MSMSVar  
 
Where, MSR was the mean of square of the reduced model; MSF was the mean of square 
of the full model. 
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3.3.2 Association analysis 
All association analyses were performed with SAS software version 9.2 using PROC 
freq, PROC logistic and PROC GLM (SAS Inc., Cary, NC, USA). Genotype frequency 
deviation from Hardy-Weinberg equilibrium was analyzed by χ² test. The association 
between SNPs and phenotypic variation was analyzed using a GLM and logistic 
procedure of the SAS package. The logistic model was used for all the ordinary traits. 
Odds ratio (OR) and 95% confidence interval (CI) were calculated as an estimate of 
risk. A general linear model was fitted for the DXA traits. The analyses were done for 
each gene separately within each of the pig populations. Apart from the fixed effect of 
the genotype, the model included the fixed effect of parity for all traits in the DuPi 
population. Average daily gain was used as covariate for leg and feet score and age was 
used as covariate for OC score. Slaughter weight and carcass length were used as 
covariate for DXA traits. The association model for the commercial population included 
the fixed effect of sex and slaughter weight as covariate. The model for association 
analysis was: 
Yijkl  =  µ   +  GENOj + Fixk + Covl + eijkl  
Where: Yijkl    = the phenotype traits measured on the individual i   
   µ   = the overall mean of the trait 
  GENOj        = the fixed effects of SNP genotype for each gene j   
  FIXk           = the fixed effects for traits k 
  COVl        = the covariance for traits 
  eijkl               = the residual error associated with the observation 
 
 
In addition, a principal component analysis (PCA) was conducted with the PRINCOMP 
procedure of the SAS package. The first component of PCA is the mathematical 
combination of measurements explaining the largest amount of variability in the data, 
and the association analyses between the SNPs and principal components (PC1, PC2 
and PC3) in this study were performed using the GLM model as described above. 
Results 43 
4 Results  
 
4.1 Phenotype characteristic of the DuPi resource population 
The descriptive statistics of leg weakness related traits are given in Table 7 and 8. The 
results showed that parity, carcass length, slaughter weight, age and average daily gain 
had an effect on the measured traits (Table 9). Parity, carcass length and average daily 
gain showed an effect on FLS but only average daily gain (ADG) had an effect on RLS. 
Parity showed effects on FFS, HH, CMH and HF. Moreover, age was also found to 
have an effect on HF. Parity, carcass length and slaughter weight affected all DXA traits 
(Table 10). BMD and BMC were highly correlated (P < 0.01) with the slaughter weight 
of the animals (r = 0.54 and 0.71, respectively).  
Principle component (PC) analysis was performed on leg and feet scores and OC scores 
separately because of the low phenotypic correlations between the traits. For leg and 
feet scores, the cumulative proportion of the first three principal components (PC1, PC2 
and PC3) reached 86%. The PC1 was mainly comprised of fore and rear leg scores, 
which explained 63% of total variation. For OC traits, PC1, PC2 and PC3 accounted for 
80% of total variation. The PC1 mainly included OC scores at HH and HF obtained 
around 57% of total variation (Table 11). 
 
4.1.1 Leg and feet scores 
The highest percentage of the animals showed moderate fore feet score (FFS) (79.35%) 
and good rear feet scores (RFS) (54.52%). Only 9.03% and 1.29% animals showed poor 
feet scores for fore and rear feet, respectively. For the fore leg score (FFS), the highest 
numbers of animals were in score 2 (42.26%). In case of rear leg scores (RLS), the 
highest number of animals were in score 3 (54.84%). Only a low percentage of animals 
had very poor leg score (4.84% for fore leg and 0.32% for rear leg). The phenotypic 
correlations (Table 8) among FLS, RLS, FFS and RLS were low to medium, ranging 
from 0.19 to 0.44.  
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4.1.2 Osteochondrosis score 
Head of humerus (278) of shoulder joint and condylous medialis humeri (CMH) (279) 
of elbow joint of pig left fore limb and head of femur (274) of hip joint and condylous 
medilais femori (CMF) (277) of knee joint of pig left hind or rear limb were considered 
for the present study. OC lesions observed were defined 13.99, 7.94, 46.30 and 31.77% 
with score 1, 2, 3 and 4, respectively. However, CMF of knee joint was found to be 
exposed highest to severe OC score (score 1) than other bones. HH of shoulder joint 
was exposed lowest to score 1. On the other hand, CMH and HH of fore limb showed 
higher healthy score (score 4) than that of CMF and HF. This observation suggested that 
fore limb is less susceptible to OC than the rear limb. However, the distribution, shown 
in Table 13, indicated that the majority of the animals had some problems. The 
phenotypic correlations (Table 8) among OC score were very low, ranging from -0.13 to 
0.12.  
 
4.1.3 DXA traits 
The difference of DXA traits between sexes is given in Table 9. BMD and BMC were 
higher in castrated males than in females. However, BMD and BMC were not 
significantly different between castrated males and females pigs in this study. A strong 
positive phenotypic correlation between BMD and BMC was found (r = 0.70, P<0.01). 
BMC showed significant (P ≤ 0.01) and strong correlations with BMD (r = 0.7) and 
BMA (r = 0.6). On the contrary, BMA showed significant (P ≤ 0.01) weak and negative 
correlation with BMD (r=-0.2).  
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Table 7: Numbers and percentage of animals at different leg and feet and 
osteochondrosis scores1 
Trait1 (n) Number (%) 
Leg score2  5 4 3 2 1 
FLS (310) 64(20.65) 131(42.26) 64(20.65) 36(11.61) 15(4.84) 
RLS (310) 170(54.84) 107(34.52) 25(8.06) 7(2.26) 1(0.32) 
      
Feet score3   3 2 1 
FFS (310)   36(11.61) 246(79.35) 28(9.03) 
RFS (310)   169(54.52) 137(44.19) 4(1.29) 
      
OC score4  4 3 2 1 
HH (278)  109 (39.21) 136 (48.92) 19 (6.83) 14 (5.04) 
CMH (279)  125 (44.80) 109 (39.07) 15 (5.38) 30 (10.75) 
HF (274)  74 (27.01) 156 (56.93) 19 (6.93) 25 (9.12) 
CMF (277)  44 (15.88) 112 (40.43) 35 (12.65) 86(31.05) 
Total (1108)  352 (31.77) 513 (46.30) 88 (7.94) 155 (13.99) 
1FLS : front leg score, RLS : rear leg score, FFS : front feet score, RFS : rear feet score, 
HH : Osteochondrosis (OC) at head of humerus, HF: OC at head of femur, CMH: OC at 
condylus medialis humeri, CMF: OC at condylus medialis femoris 
2 on a scale 1 (poor, very blukled), 3 (very good) and 5 (poor, flexing) 
3on a scale 1 (poor) to 3 (good) 
4on a scale 1 (poor) to 4 (good) 
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Table 8: Statistics and phenotype correlation between leg and feet and OC scores 
 
Phenotype correlation Traits1 N Mean SD Min Max FLS RLS FFS RFS HH CMH HF CMF 
FLS 310 2.65 1.08 1 5  0.28 0.23 0.22 0.08 -0.02 0.02 -0.04 
RLS 310 2.70 0.66 1 5   0.23 0.19 -0.08 -0.003 -0.003 -0.05 
FFS 310 2.02 0.45 1 3    0.44 -0.08 -0.12 0.01 -0.07 
RFS 310 2.53 0.53 1 3     -0.01 -0.06 0.04 -0.13 
HH 278 1.78 0.78 1 4      0.12 0.07 -0.007 
CMH 279 1.82 0.95 1 4       0.11 -0.07 
HF 274 1.98 0.84 1 4        -0.10 
CMF 277 2.59 1.09 1 4         
1FLS=fore leg score; RLS=rear leg score; FFS=fore feet score; RFS=rear feet score; HH= OC score at head of humerus;  
CMH= OC score at condylus medials humeri; HF= score OC at head of femur; CMF= score OC at condylus medialis femori. 
 
Table 9: Descriptive statistics of BMD, BMC and BMA of the DuPi resource population 
Total Female  Castrated male 
Traits1 Mean 
±SD 
Min Max N Mean 
±SD 
Min Max n Mean 
±SD 
Min Max Mean 
±SD 
n 
BMD 
(g/cm2) 
0.96 
±0.08 
0.69 1.25 275 0.95 
±0.07 
0.79 1.172 145 0.96 
±0.09 
0.69 1.25 0.96 
±0.09 
130 
BMC  
(g) 
66.72 
±7.07 
45.53 87.36 275 66.38 
±6.03 
45.53 83.29 145 67.02 
±7.69 
48.42 87.36 67.02 
±7.69 
130 
 BMA 
(cm2) 
69.67 
±5.26 
55.91 84.64 275 69.75 
±5.22 
55.91 84.64 145 69.62 
±5.36 
57.36 83.29 69.62 
±5.36 
130 
1BMD : Bone mineral density, BMC : Bone mineral content,  BMA: Bone area. 
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Table 10: Effect of production and carcass traits on leg and feet scores, OC score and DXA traits1 
Traits 
n Mean 
±SE 
Mini/max Model R2 Dam Sire Age ADG 
 
Slaughter 
weight 
Carcass 
length 
Parity 
FLS 310 2.65±0.94 1/5 *** 0.38 *** * ns ** ns * *** Leg score 
 RLS 310 3.17±0.55 1/5 * 0.02 ns ns ns * ns ns ns 
FFS 310 2.02±0.44 1/3 ** 0.18 * ns ns ns ns ns * Feet score 
RFS 310 2.53±0.48 1/3 *** 0.21 *** ns ns ns ns ns ns 
HH 278 1.78±0.74 1/4 ** 0.21 * ns ns ns ns ns ** 
CMH 279 1.82±0.89 1/4 *** 0.24 ** ns ns ns ns ns *** 
HF 274 1.98±0.81 1/4 * 0.20 * ns ** ns ns ns *** 
OC 
 
 
 CMF 277 2.59±1.08 1/4 * 0.02 * ns ns ns ns ns ns 
BMD 275 0.96±0.07 0.69/1.25 *** 0.42 * ns ns ns *** ns *** 
BMC 275 66.72±4.31 45.53/87.36 *** 0.68 *** ns ns ns *** *** ** 
DXA 
BMA 275 69.67±3.86 55.91/84.64 *** 0.54 *** ns ns ns *** *** ** 
1FLS=fore leg score; RLS=rear leg score; FFS=fore feet score; RFS=rear feet score; HH= OC score at head of humerus; CMH= OC score at 
condylus medials humeri; HF= score OC at head of femur; CMF= score OC at condylus medialis femori, BMD : Bone mineral density, 
BMC : Bone mineral content,  BMA: Bone area. ADG= average daily gain
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Table 11: Rotated factor pattern and final communality1 estimates from principal 
component analysis of leg weakness-related traits2  
Component 
Traits h2 
1 2 3 
HH 0.72 0.87 0.17 0.01 
HF 0.32 0.05 -0.04 0.99 
CMH 0.52 0.61 -0.47 0.12 
CMF 0.75 0.07 0.91 -0.02 
FLS 0.81 -0.08 0.04 0.99 
RLS 0.33 -0.10 0.99 0.04 
FFS 0.72 0.86 -0.03 -0.03 
RFS 0.70 0.83 -0.11 -0.08 
 
1
 Communality estimates appear in column headed h2 
2 FLS=fore leg score; RLS=rear leg score; FFS=fore feet score; RFS=rear feet 
score; HH= OC score at head of humerus; CMH= OC score at condylus medials 
humeri; HF= score OC at head of femur; CMF= score OC at condylus medialis 
femori 
  
4.2 Phenotype characteristic of the animals used for association analysis 
The distribution of osteochondrosis scores for the commercial population is shown in 
Table 12. Among all the investigated regions, head of humerus (HH) and head of femur 
(HF) showed litter affected by OC, while the most affected regions were distal 
epiphysis (DEU), condylus medialis femoris (CMF) and condylus medialis humeri 
(CMH), respectively. 
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Table 12: Number of the animals at different OC scores1 of the commercial population   
  n (scores) 
Male 1 2 3 4 5 6 
Head of humerus 130 - - - - - 
Condylus medialis humeri 110 8 12 - - - 
Condylus lateral humeri 125 4 1 - - - 
Radius/Ulna prox 119 11  - - - 
Distal epiphys. Fug Ulna 15 62 6 14 32 1 
Head of femur 129 1 - - - - 
Condylus medialis 
femoris 85 37 7 1 - - 
        
Female 1 2 3 4 5 6 
Head of humerus 166 - 2 1 - - 
Condylus medialis humeri 130 23 16 - - - 
Condylus lateral humeri 166 - 2 4 - - 
Radius/Ulna prox 155 14 - - - - 
Distal epiphys. Fug Ulna 16 72 9 33 38 1 
Head of femur 169 - - - - - 
Condylus medialis 
femoris 104 50 14 1 - - 
        
Total  1 2 3 4 5 6 
Head of humerus 296 - 2 1 - - 
Condylus medialis humeri 240 31 28 - - - 
Condylus lateral humeri 291 4 3 1 - - 
Radius/Ulna prox 274 25 - - - - 
Distal epiphys. Fug Ulna 31 134 15 47 70 2 
Head of femur 298 1 - - - - 
Condylus medialis 
femoris 189 87 21 2 - - 
 1
 Lesions are scored from 1 to 6 with score 1= normal and score 2 to 6 = mild 
to severe lesions 
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4.3 QTL for leg weakness related traits 
A total of 16 chromosomal QTL regions (Table 13) were identified for leg weakness 
related traits on ten porcine autosomes in this study. All QTL reached the 5% 
chromosome-wide significance level. In this study, most estimated QTL effects 
appeared to be isolated effects on one individual trait showing no relation to other traits. 
There were however some chromosomal regions, which influenced more than one of the 
traits, notably on SSC2 and SSC5.   
 
4.3.1 QTL for leg and feet score 
Two chromosomal regions were identified for FLS (P ≤ 0.01, CW), at 54 cM  on SSC5 
and at 16 cM on SSC13. One QTL at 0 cM (P ≤ 0.01, CW) on SSC14 was identified for 
RLS. Three QTL were identified for fore feet score (P ≤ 0.05, CW) at 166 cM, 60 cM 
and 33 cM  on SSC1, SSC5 and SSC16, respectively (Table 14). No QTL was found for 
rear feet score. 
 
4.3.2 QTL for osteochondrosis score 
The QTL for OC were located on SSC3, 5, 6, 9 and 17 (Table 14). OC score of HH was 
influenced by three QTL regions on SSC3, 6 and 9 at 7, 57 and 60 cM, respectively. 
Among them, a QTL for HH on SSC3 reached 5% genome-wide significance level, the 
remaining QTL were suggestive. A QTL for CMH was identified at 159 cM on SSC5. 
Two chromosomal regions affecting OC score of HF were identified on each of SSC9 
and 17 at 26 and 125 cM, respectively.  However, no suggestive QTL was found for OC 
score of CMF.  
 
4.3.3 QTL fore bone density traits 
Four chromosomal regions were identified affecting bone mineral-related traits, of 
which three were for BMD and one was for BMC. QTL influencing BMD were found 
on SSC2, 3 and 9 at positions 7, 82 and 33 cM, respectively. Only one QTL affecting 
BMC was found at 0 cM on SSC2 which reached 5% GW in this study. 
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Table 13: Location and estimated effected of the identified QTL for leg weakness-
related traits 
SSCa Traitb POSc Fd A±see D±sef Var%g CI95h Closest markersi 
1 FFS 166   6.55* -0.13±0.05 0.23±0.08 3.98 35 - 203 S0155 
2 BMC 0 9.36*** -2.53±0.64 4.37±2.06 6.11 0 - 103 SW2443 
2 BMD 7   4.91* -0.03±0.01 0.08±0.04 4.00 0 - 101.5 SW2443 
3 BMD 82 7.00** -0.03±0.01 -0.05±0.02 4.00 0 - 96 S0002-SW2570 
3 HH 7 8.21*** 0.07±0.09 0.71±0.18 5.24 0 - 33 SW72 
5 FFS 60   6.16* -0.00±0.05 0.22±0.09 5.50 0 - 195.5 SWR453 
5 CMH 159   4.89* -0.30±0.10 0.48±0.25 4.30 0 - 168 IGF1 
5 FLS 54 7.29** 0.04±0.09 -0.59±0.15 4.11 43 - 183 SW1482 
6 HH 57 6.17* -0.28±0.09 -0.32±0.19 3.80 19.5 - 150 S0087 
9 BMD 33 5.28* 0.05±0.02 0.19±0.08 4.00 0 - 167 SW21-MMP3 
9 HH 60 5.26* -0.31±0.17 -1.65±0.57 3.17 36 - 158 MMP3 
9 HF 26 4.98* -0.20±0.20 -0.22±0.90 4.40 0 - 167 SW21-MMP3 
13 FLS 16 9.16** -0.31±0.10 0.60±0.22 5.26 0 - 74 S0219 
14 RLS 0 6.62** 0.12±0.09 -0.44±0.13 3.69 0 - 142 SW857 
16 FFS 33 4.87* -0.15±0.28 -2.09±0.69 3.18 0 - 156 S0111-S0026 
17 HF 125 6.42* -0.71±0.20 0.92±0.54 4.06 41 - 140 SW2431 
a Sus scrofa chromosome. 
bTrait abbreviations: FLS= fore leg score; RLS= rear leg score; FFS = fore feet score; 
RFS = rear feet score; OC=osteochondrosis; HH= OC at head of humerus; CMH= OC 
at condylus medials humeri; HF= OC at head of femur; CMF= OC at condylus medialis 
femori; BMD = bone mineral density; BMC = bone mineral contents. 
cchromosomal position in Kosambi cM. 
dSignificance of the QTL: *, significant on a chromosome-wide level with P ≤ 0.05; **, 
significant on a chromosome-wide level with P  ≤  0.01; ***, significant on a genome-
wide level with P  ≤  0.05. 
eAdditive effect and standard error. Positive values indicate the Duroc alleles result in 
higher values than Pietrain alleles; negative values indicate that Duroc alleles result in 
lower values than Pietrain alleles.    
fDominance effect and standard error. 
gThe percentage of phenotypic variance explained by the QTL 
h95% confidence interval. 
iThe marker closest to the QTL peak as close as possible. 
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Figure 11: Evidence of QTL for leg weakness related traits on SSC2 and SSC3. Marker 
positions along each chromosome are indicated in cM on the x-axis, the y-axis 
showed F values. The 5% chromosome-wide, 1% chromosome-wide, 5% 
genome-wide were indicated by solid, horizontal dashed, and dotted-line, 
respectively 
 
 
4.4 Gene characterization and detection of polymorphisms 
4.4.1 Collagen type II alpha I (COL2A1) 
The porcine COL2A1 mRNA sequence (GenBank: XM_001925959.1) consists of 2550 
bp. The porcine COL2A1 protein consists of 849 amino acids which show 95% 
homology to the human and canine sequences (GenBank: AAC41772.1 and 
NP_001006952.1, respectively). Porcine COL2A1 consist of 38 exons with the sequence 
range from 6 to 143 nt (Figure 12). The comparative sequencing analysis revealed 8 
SNP in the intron 29 (Table 14). One silent SNP (GenBank: FJ788665 g.80C>T) was 
selected for genotyping. 
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 Table 14: List of detected SNP in porcine COL2A1 gene 
Acc No, SNP site F Primer R Primer Position SNP 
FJ788665 g.80 C>T COL2A1-F1 COL2A1-R1 I-29 C-T 
FJ788665 g.85 C>T COL2A1-F1 COL2A1-R1 I-29 C-T 
FJ788665 g.97 C>T COL2A1-F1 COL2A1-R1 I-29 C-T 
FJ788665 g.156 G>A COL2A1-F1 COL2A1-R1 I-29 G-A 
FJ788665 g.184 C>T COL2A1-F1 COL2A1-R1 I-29 C-T 
FJ788665 g.244 G>A COL2A1-F1 COL2A1-R1 I-29 G-A 
FJ788665 g.273 G>A COL2A1-F1 COL2A1-R1 I-29 G-A 
FJ788665 g.335 C>T COL2A1-F1 COL2A1-R1 I-29 C-T 
  
 
 
 
Figure 12: Porcine COL2A1 gene structure and position of the identified SNP 
 
4.4.2 Collagen type X alpha I (COL10A1) 
The porcine COL10A1 mRNA sequence (GenBank: NM_214392.1) consists of 2125 bp 
including 97 bp of 5′ untranslated region (UTR) and 2028 bp of the coding region. The 
gene consists of 3 exons ranging from 82 to 1870 nt. The gene encodes a 675 amino 
acid protein which shows 100% homology to the bovine (GenBank: NP_777059.1), 
100% to the human (GenBank: NP_000484.2) and 77% to the murine sequence 
(GenBank: CAA44741.1). The comparative analysis between porcine mRNA sequences 
(GenBank: NM_001005153.1) and the genomic DNA sequence (GenBank: 
NC_010443.1) revealed that the structure of porcine COL10A1 gene contains 3 exons. 
Comparative sequencing showed 1 SNP within 3′ UTR (g.72 C>T, GenBank: 
AF222861).   
      
FJ788665 g.80C>T  
1 38 
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Figure 13: Porcine COL10A1 gene structure and position of the identified SNP (gray 
colour indicated the UTR regions) 
 
4.4.3 Matrix gla protein (MGP) 
The porcine MGP mRNA sequence (GenBank: GU391766.1) consists of 606 bp 
including 69 bp of 5´UTR, 312 bp of coding region and 225 bp of 3´UTR. The coding 
region encodes 103 amino acids (GenBank: ADD22717) which show 100% homology 
to the human (GenBank: CAA37418.1), 100% to the bovine (GenBank: NP_777132.1) 
and also 100% to the murine sequences (GenBank: BAE35492.1). None of the 
polymorphisms was identified at the 5´UTR of the porcine MGP. Three SNP 
(g.115A>G, g.1073C>T and g.1135C>A; all positions refer to Genbank accession 
number NC_010447: region 22960152 to 22964239) were located in intron 1 and one 
SNP was located at 3´UTR (g.3767C >T). For association analysis, a SNP g.3767C >T 
was selected for genotyping. 
 
 
 
Figure 14: Porcine MGP gene structure and position of the identified SNP (gray colour 
indicated the UTR regions) 
1 2 3 
NC_010447   g.3767C >T  
4 
1 2 3 
AF222861  c.72C >T  
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4.4.4 Matrix metallopeptidase 3 (MMP3) 
The porcine MMP3 mRNA sequence (GenBank: NM_001166308) consists of 1640 bp. 
The coding region encodes 477 amino acids (GenBank: NP_001159780). The structure 
of the porcine MMP3 gene was deducted by comparison of the porcine MMP3 mRNA 
sequence, human MMP3 mRNA sequence (GenBank: NM_002422) and human 
genomic DNA sequence (GenBank: NC_000011.9) and revealed 10 exons. Screening 
for SNP showed one SNP in the intron 2 (GenBank: FJ788664 g.158 C>T) which was 
selected for genotyping. 
  
 
Figure 15: Porcine MMP3 gene structure and position of the identified SNP (gray colour 
indicated the UTR regions) 
 
 
4.4.5 Transforming growth factor beta 1 (TGFβ1) 
The porcine TGFβ1 mRNA sequence (GenBank: NM_214015) consists of 3206 nt. The 
coding region encodes 390 amino acids (GenBank: NP_999180.1). The structure of 
porcine TGFβ1 gene was deducted by comparison of the porcine TGFβ1 mRNA 
sequence, the human TGFβ1 mRNA sequence (GenBank: NM_000660) and the human 
genomic DNA sequence (GenBank: NC_000019.9) and revealed 7 exons. The SNP 
identified in the intron 6 (GenBank: g.797 G>A, GenBank: AF461808) was used for 
genotyping. 
 
1 2 7 
FJ788664 g.158 C>T  
9 3 4 5 6 10 8 
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Figure 16:  Porcine TGFβ1 gene structure and position of the identified SNP (gray 
colour indicated the UTR regions) 
 
 
4.5 Association of candidate genes with leg weakness related traits 
In this study, only MMP3, COL10A1, and TGFβ1 were genotyped in both populations. 
COL2A1 and MGP were successful genotyped only in the DuPi population due to the 
lack of DNA from the commercial population. Genotype and allele frequencies of each 
SNP are presented in Table 15. Single SNPs were identified in each of MMP3 (g.158 
C>T, GenBank: FJ788664), COL10A1 (g.72 C>T, GenBank: AF222861) and TGFβ1 
(g.180 G>A, GenBank: AJ621785). The SNP genotype frequencies of MMP3 g.158 
C>T and COL10A1 g.72 C>T in the DuPi and of TGFβ1 g.180 G>A in the commercial 
population deviated from Hardy Weinberg equilibrium. In contrast, genotype 
frequencies of MMP3 g.158 C>T and COL10A1 g.72 C>T in the commercial population 
and TGFβ1 g.180 G>A in DuPi population were in Hardy Weinberg equilibrium (P ≤ 
0.05).  
The associations between polymorphisms of TGFβ1, MMP3 and COL10A1 genes and 
leg, feet and OC scores were estimated by calculating OR and 95% confidence intervals 
(CI). The results (Table 17) showed that scores of OC at the HF region in the DuPi 
population increased 2.003–fold (95% CI>0.920-4.362) with at least one homozygous 
genotype MMP3 g.158 CC compared with another homozygous genotype g.158 TT. A 
significant association was found between TGFβ1 g.180 G>A and RLS in the DuPi 
population, with the decrease of 0.377-fold (AA-genotype is reference, 95% CI>0.164-
0.867). However, no significant results were found in genotype and allele frequencies of 
1 2 7 
AF461808 g.797 G>A  
3 4 5 6 
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TGFβ1 g.180 G>A, MMP3 g.158 C>T, and COL10A1 g.72 C>T with the OC traits in 
the commercial population.  
Considering the effects of TGFβ1 g.180 G>A, MMP3 g.158 C>T, and COL10A1 g.72 
C>T SNPs on bone mineral status of the DuPi population, a significant association was 
found between MMP3 g.158 C>T genotype with BMD, BMC and BMA traits (Table 
16). Comparing the different  genotypes,  MMP3 g.158 CC genotype had a higher least 
square mean of BMD compared with g.158 TT genotype (0.976 ± 0.008 g/cm2 vs 0.943 
± 0.01 g/cm2), with a significant additive effect for allele C (0.016 ± 0.007 g/cm2 , P 
=0.07).  The heterozygous genotype MMP3 g.158CT showed a higher BMC and BMA 
than both of the homozygous genotypes. No significant differences were observed for 
COL10A1 g.72 C>T and TGFβ1 g.180 G>A with any of the DXA traits (data not 
shown). 
 
For the association between SNPs and PCs, the SNP TGFβ1 g.180 G>A showed a 
significant (P < 0.05) association with PC2 of feet and legs scores and was almost (P = 
0.054) associated with PC3 of OC scores (Table 18). The SNPs of the genes COL10A1 
and MMP3 were not association with any of the PCs. From the results of association 
analyses for single traits and PCs, the TGFβ1 gene was significantly (P < 0.05) 
associated  with leg score traits.  
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Table 15: Allele and genotype frequencies and Hardy Weinberg equilibrium of the three SNPs in the MMP3, COL10A1 and TGFβ1 genes 
SNP Allele 
 DuPi 1 
(Frequency, %) 
CP2 
(Frequency, %) 
Genotype DuPi 
(Frequency, %) 
HWE3 
χ2 (p) 
CP 
(Frequency, %) 
HWE 
χ2 (p) 
C 58.85 45.89 CC 29.50 19.64 
T 41.15 54.11 CT 58.70 52.5 MMP3 
   TT 11.80 
4.49 
(0.03) 27.86 
0.91 
(0.34) 
C 53.05 83.96 CC 35.26 70.42 
T 46.96 16.04 CT 35.58 27.11 COL10A1 
   TT 29.17 
8.17 
(0.004) 2.46 
0.01 
(0.89) 
A 67.64 83.21 AA 47.95 71.32 
G 32.36 16.79 AG 39.38 23.77 TGFβ1 
   GG 12.67 
1.01 
(0.31) 0 
5.91 
(0.02) 
1
 DuPi: Duroc x Pietrain population; Pi : Pietrain population, 2CP : Commercial population, 3HWE : Hardy weinberg equilibrium test 
 
Table 16: Association of MMP3 g.158 C>T with bone density traits in the DuPi1 resource population 
Genotype (Lsmean ± SE)3 Effect (Lsmean ± SE)4 
Traits2 
CC CT TT Additive Dominance 
BMD 0.976 (0.008)a 0.956 (0.006)a,b 0.943 (0.01)b 0.016 (0.007)* 0.0039 (0.01) 
BMC 66.75 (0.56)a,b 67.11 (0.45)a 64.88 (0.89)b 0.935 (0.523) -1.295 (0.688) 
BMA 68.48 (0.54)a 70.31 (0.43)b 68.78 (0.85)a,b -0.149 (0.502) -1.679 (0.659)* 
1DuPi: Duroc x Pietrain population; Pi : Pietrain population 
2BMD : Bone mineral density, BMC : Bone mineral content ,  BMA; Bone area. 
3Least square mean values with superscripts a and b are different at P < 0.05.   
4Least square mean values of additive (a) and dominance (d) effects of MMP3 alleles: * P ≤ 0.05 
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Table 17: Association of SNP in the MMP3, COL10A1 and TGFβ1 genes with leg 
weakness related traits in the DuPi1 and commercial populations 
  Population Genes Traits2 OR3 95% CI4 P5 
HH 0.797 0.369-1.722 0.79 
HF 2.003 0.920-4.362 0.04** 
CMH 0.831 0.386-1.790 0.68 
CMF 0.926 0.444-1.932 0.77 
FLS 1.898 0.785-4.590 0.12 
RLS 0.734 0.345-1.562 0.23 
FFS 0.828 0.322-2.127 0.47 
MMP3 
 
 
 
 
 
 
 
 
 RLS 1.011 0.473-2.159 0.56 
HH 1.521 0.851-2.718 0.36 
HF 1.191 0.662-2.144 0.72 
CMH 0.91 0.522-1.587 0.06* 
CMF 0.963 0.555-1.673 0.15 
FLS 1.907 1.040-3.499 0.10 
RLS 0.973 0.554-1.708 0.98 
FFS 1.116 0.550-2.262 0.76 
COL10A1 
 
 
 
 
 
 
 
 
 RLS 0.871 0.496-1.529 0.86 
HH 0.738 0.350-1.555 0.53 
HF 0.679 0.315-1.462 0.14 
CMH 0.854 0.399-1.828 0.85 
CMF 0.771 0.373-1.596 0.68 
FLS 1.491 0.678-3.283 0.61 
RLS 0.377 0.164-0.867 0.03** 
FFS 2.699 1.054-6.913 0.08* 
 
 
 
 
 
 
 
 
 
 
 
 
 
DuPi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TGFβ1 
 
 
 
 
 
 
 
 
 RLS 1.606 0.746-3.457 0.10* 
CMH 1.53 0.63-3.73 0.63 
DEU 1.07 0.56-2.03 0.93 
MMP3 
 
 CMF 0.96 0.47-1.96 0.95 
CMH na Na na 
DEU 1.1 0.27-4.37 0.99 
COL10A1 
 
 CMF 2.16 0.52-8.98 0.56 
CMH 0.39 0.05-2.92 0.6 
DEU 0.41 0.23-3.03 0.19 
 
 
 
Commercial 
population 
 
 
 
 
 
TGFβ1 
 
 CMF 2.07 0.71-6.02 0.36 
1DuPi: Duroc x Pietrain population. 2Estimates odds ratio test between homozygous genotype. 
395% Wald confidence limits. 4Significant level*P≤0.10, **P≤0.05, ***≤0.01. 
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Table 18: The association analyses between SNP of TGFβ1 and principal components 
of the Dupi1 population 
LSM3 
Traits2 
AA AG GG 
P value 
OC PC1 0.042 -0.022 -0.107 0.79 
OC PC2 0.050 -0.069 -0.062 0.70 
OC PC3 0.203a -0.172b 0.009 0.05 
FL PC1 -0.115 -0.071 0.228 0.17 
FL PC2 -0.014 0.081a -0.411b 0.04 
FL PC3 -0.012 0.018 0.019 0.57 
1
 DuPi: Duroc x Pietrain population 
2OC: Osteochondrosis scores, PC: Principle component, FL: Feet and legs scores 
3 Least square mean values with superscripts a and b are different at P < 0.05. 
 
4.6 Expression of candidate genes in OC cartilage 
Initial studies were performed to investigate the expression of two internal controls 
GAPDH and TBP in normal and OC cartilage in order to justify them as internal 
control. The results showed that expression of GAPDH and TBP were not different 
between OC and normal cartilage, this means that the expressions of both genes are 
accurate to be used as the internal control (Figure 18). Relative expression levels of 6 
genes known to be important in the regulation and involved in the endochondral 
ossification were examined in OC lesions and healthy cartilage in this study. The 
mRNA expression of TGFβ1 and RUNX2 were significantly higher (P ≤ 0.05) in the 
OC cartilages compared with healthy cartilage (Figure 18). There were no significant 
differences in mRNA expression of MMP3, SOX9, MMP9 and COL10A1 genes (Figure 
17 and Figure 18). However, MMP3 tended to be expressed lower in OC cartilage while 
SOX9 tended to be up regulated in OC lesions. MGP was lower expressed in OC 
cartilage (Figure 20). Among the genes examined, the transcription factor SOX9 gene 
was highest expressed where MMP9 was lowest expressed in articular cartilage 
compared with the other genes.   
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Figure 17: Relative expression of (A) MMP3, (B) TGFβ1, (C) COL10A1, (D) MGP 
genes in healthy (HT) and osteochondrosis (OC) cartilage. Results 
presented as mean ± SD     
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Relative expression of (A) COL2A1, (B) MMP9, (C) SOX9 and (D) RUNX2 
in healthy (HT) and osteochondrosis (OC) cartilage. Results presented as 
mean ± SD, *P<0.05  
 
Results     62 
4.7  Molecular characterization of the MGP gene 
4.7.1 Characterization of the porcine MGP gene   
The genomic sequence of MGP was PCR amplified and sequenced using 
oligonucleotide primers designed from the MGP sequence (GenBank NC_010447, 
region 22960152 to 22964239). The coding region of the porcine MGP contains four 
exons and three introns. The intron-exon organization of the genomic MGP sequence is 
shown in Table 19. Comparison of the porcine with the human MGP gene revealed that 
the lengths of the exons and introns were almost identical. The full-length MGP cDNA 
isolated from articular cartilage consists of 606 bp with a 69-bp 5′ UTR, a 312-bp open 
reading frame with a start codon, and a 225-bp 3′ UTR (GenBank accession 
GU391766). The amino acid sequence similarity between porcine MGP and MGP 
proteins from man, cattle, rat and mouse was determined by the Clustal method (Figure 
19). The alignment showed that the porcine MGP shares common structures and 
functional elements with MGP orthologous from other species. Completely conserved 
regions of protein sequence are present in almost all of the aligned mammalian 
sequences at the glutamic acid (E) residues.  
 
 
Table 19: Discription of exon and intron boundary of the porcine MGP gene 
Exon bp Splicing donor Intron Splicing acceptor 
1 60 CCTGTGCTATgttgag 1437  tcgagAATCTCATGA 
2 33 TATGAAATCAgtaagt 1091 ttaaagATCCCTTCCT 
3 78 CCCAAGAGAGgtgggt 972 ttctagAATCCGAGAA 
4 287 GGCCAAATAAGaccag    
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Figure 19: A comparison of the peptide sequence of the porcine MGP (GenBank 
accession NP_999281.1) protein with the peptide of the human (GenBank 
accession NP_000891.2), bovine (GenBank accession NP_777132.1), rat 
(GenBank accession NP_036994.1) and mouse (GenBank accession 
NP_032623.1). Identical amino acid residues are indicated by asterisk. 
Conserved glutamic acid (E) residues are bounded 
 
 
4.7.2  MGP expression in healthy and osteochondrosis cartilage  
The Western blot result showed that the MGP protein expression was lower (P < 0.05) 
in OC compared with normal cartilage. This appeared to be consistent with results from 
the transcription level. The bar graph depicts the means (+SD) ratio of intensity of 
MGP-to-GAPDH bands showed in figure 21B and 21C.  
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Figure 20: Expression analysis of the MGP gene and protein in articular cartilage of pig 
(A) Quantitative real-time RT-PCR analysis of porcine MGP mRNA in  
healthy and osteochondrosis cartilage of all investigated animals, condylus 
medialis humeri (elbow joint) and condylus medialis femuris (knee joint). 
The presented values are the means of duplicate determinations with 
standard errors. (B) Western blot analysis of MGP and GAPDH protein 
expression in osteochondrosis (OC) and healthy articular cartilage (HT) 
(M=Protein marker). (C) The relative intensity graph normalized by GAPDH 
band. The presented values are the intensity of the means with standard 
deviation of three different biological experiments. *P<0.05   
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4.7.3 MGP localization by immunofluorescence  
The distribution of the MGP protein was detected throughout different zones of articular 
cartilage. Positive immunostaining for MGP was detected in all layers of articular 
cartilage (Figure 22). The staining was mainly seen in the extracellular matrix, although 
weak immunoreactivity was found in the cytoplasm of chondrocytes. In the articular 
cartilage of newborn and 2 month-old animals, almost all cartilage canals were 
surrounded by an immunopositive signal of MGP. The staining intensity tended to 
decrease with age. The control cartilage specimens showed no immunoreactivity to 
MGP.  
 
4.7.4 DNA methylation pattern of the MGP promoter  
We analyzed the methylation status of the computationally predicted CpG islands using 
genomic DNA isolated from the OC and healthy cartilage of the full-sib pairs from F2 of 
the DuPi resource population. The use of DNA from these animals allowed us to 
minimize possible effects of genetic background except OC on the methylation status of 
the analyzed animals. The MethPrimer program predicted that the CpG number was 10 
in the CpG islands which was validated in the sequence of PCR products of MGP 
derived from bisulfite-converted DNA. There are 4 CG sites that include putative 
transcription factor binding sites for SRY, CDP-CR, Est-1 and T1 at the CG number 2, 
4, 5 and 10 respectively (Figure 23A). The bisulfite sequencing analysis revealed that 
the overall methylation percentages were not differed between OC and healthy, but it 
tended to be higher in OC samples. However, the methylation percentages of 3 specific 
CpG sites (CpG2, CpG7 and CpG9) were higher in OC samples (Figure 23B) than in 
healthy (CpG2: 5 vs 32.5%; CpG7: 34.58 vs 78.33%; CpG9: 10 vs 48.33%) samples.  
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Figure 21: Immunolocalization of MGP in articular cartilage of 1-day, 2-month and 6-month olds pigs. Staining for MGP was detected 
around cartilage canals of 2-month and 6-month olds pigs (20X) 
FITC                                      DAPI                           MERGE 
Control 2nd Antibody Antibody anti MGP 
New born 
 
 
 
 
 
 
2 Month 
 
 
 
 
 
 
 
6 Month 
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Figure 22: MGP gene structure and methylation of MGP promoter. (A) 
Diagrammatic representation of the MGP gene and its promoter region 
which contains the identified SNP, putative binding sites of TATA box 
and CpG region. Exons are shown as boxes. The CG sites are indicated 
(-543 to -709). Putative binding sites for transcription factors located in 
the CpG site are indicated by name. (B) Methylation percentage of 
normal and OC cartilage derived DNA.*P<0.05   
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5 Discussion  
 
5.1 Characterization of phenotype related to leg weakness traits 
As a result of genetic improvement, modern pigs have a high growth rate and increased 
weight load on immature bone and cartilage, which contributes to a higher incidence of 
OC (Jørgensen 2000, Kadarmideen et al. 2004). The long bones are formed through an 
endochondral ossification process, where cartilage cells are replaced gradually by bone 
matrix. Therefore, the disorders of bone and cartilage are thought to be connected. 
However, both BMD and OC are reported to have a genetic background and are directly 
related to each other through genetic factors (Jørgensen and Nielsen 2005, Kadarmideen 
and Janss 2005b, Mao et al. 2008). No studies are found in pigs to address the 
relationship between BMD and OC. In this study we found a negative correlation 
between BMD and OC which is in good agreement with a study in horses in which a 
correlation between the high degree of OC with a low level of BMD is reported (Firth et 
al. 1999). Clear understanding of OC pathogenesis is important to prevent this disease 
and to improve the disease resistance in pigs, which is important for animal welfare. 
Moreover, reducing the losses due to the disease is an excellent way of improving 
production efficiency in pigs. OC has mainly been studied in chronic stages because a 
definitive histological diagnosis is difficult in affected animals, therefore the clinical or 
acute OC is mostly diagnosed using radiography (Jørgensen et al. 1995).   
In this study we found that the frequency of OC is high (31.05%) in the CMF region of 
the knee joints, which is supported by previous reports (Kadarmideen et al. 2004). 
Moreover, the results showed that OC was higher in castrated male pigs than in females 
which also coincides with previous results found in Norwegian Landrace (Ytrehus et al. 
2004c). It was observed that the degree of OC in the fore legs of Duroc breed showed 
the highest incidence compared to other European pig breeds (Pietrain, Dutch Landrace 
and Great Yorkshire)  (Van der Wal et al. 1978). In contrast, the boar femur was less 
affected by OC in the Duroc compared to Pietrain breeds in the same study. Edwards et 
al. (2006) reported that Duroc-sired progeny were heavier than Pietrain-sired at 26 wk 
of age.  
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In addition to OC, bone mineral density (BMD) is generally regarded as important 
parameter to assess bone growth and is associated with risk of bone fracture and with 
structural soundness in pigs (Mitchell et al, 2000, Mitchell et al, 2001). Studies in 
human have shown that BMD variation can be explained by genetic factors (Amin et al. 
2004, Xu et al. 2009). In this study, BMD and BMC were not significantly different 
between castrated males and females pigs. Strong positive phenotype correlation among 
BMD and BMC was found (r2 = 0.70, P<0.01), indicating that causal genes might have 
effects on both BMD and BMC traits. BMD and BMC are also strongly correlated (P < 
0.01) with the slaughter weight of animals (r2 = 0.54 and 0.71, respectively).   
 
5.2 QTL for leg weakness related traits 
The genetics of leg weakness related traits such as osteochondrosis in pigs is complex 
and multiple variables might contribute to the development of the disease.  Due to this 
complexity, identification of the genomic loci affecting leg weakness traits is critical 
and important. A number of factors are known to influence the development of leg 
weakness or OC (Jorgensen and Nielsen 2005), specially body and leg structure of the 
animal, growth rate, mechanical stress and body weight of the animals. Performing QTL 
studies using exotic breeds crossed with the European breed may not be accurate. Using 
this type of animals will undoubtedly lower the incidence of leg weakness or OC and 
the too low frequency of the disease might influenced the existence of QTL. Moreover, 
it has not been clear that identification of QTL regions in pig using crosses between 
divergent populations has any significance for the selected populations used in 
commercial agriculture (Evans et al. 2003). In addition, it has been reported that the 
degree of leg weakness and OC of one sex in a breed cannot be translated to the other 
sex within that breed, nor to the same sex of  another breed (Van der Wal et al. 1978). 
Therefore, using both European pig breeds for producing F2 for the QTL study might be 
more accurate for study leg weakness related traits.  
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Several QTL for leg score (Guo et al. 2009), feet score (Lee et al. 2003), OC score 
(Andersson-Eklund et al. 2000, Christensen et al. 2009) and femur BMD (Mao et al. 
2008) were previously identified in White Duroc x Erhualian, Wild boar x Large White, 
Large White x Meishan and Danish Duroc x Danish Large White intercrosses. However 
no study was carried out in Duroc x Pietrain intercross. This is the first study to map 
QTL for leg weakness related traits in Duroc and Pietrain intercross. Different QTL for 
leg and feet scores were observed, implying that these traits are controlled by multiple 
gene action.  
 
Previously, QTL analysis for leg weakness and bone-related traits were performed in 
different pig breeds including Landrace purebred (Uemoto et al. 2010), White Duroc × 
Erhualian (Guo et al. 2009, Mao et al. 2008), Large white × Meishan (Lee et al. 2003), 
Duroc × Landrace and Duroc × Large white crossbred (Christensen et al. 2009), and 
Wild boar × Large white (Andersson-Eklund et al. 2000). To the best of our knowledge 
this is the first study to map QTL for leg weakness related traits in a Duroc and Pietrain 
intercross. A total of 16 QTL were identified. Among them, some of the identified QTL 
are novel and some are supported by the previous studies (Andersson-Eklund et al. 
2000, Christensen et al. 2009, Guo et al. 2009, Lee et al. 2003, Mao et al. 2008, Uemoto 
et al. 2010). 
 
The QTL for FLS found on the SSC13 at 16 cM in the present study and QTL for the 
same traits is reported at 76 cM in the White Duroc x Erhualian intercross (Guo et al. 
2009) and at 58 cM in the Large White x Meishan (Lee et al. 2003) were on the same 
chromosome. The QTL results for RLS at SSC14 in our study at 0 cM are supported by 
QTL at 38 cM in Large White x Meishan pigs (Lee et al. 2003). A QTL for rear leg 
score observed on SSC6 close to marker SW193 (SSC6q2.1). At this region a positional 
candidate gene transforming growth factor-beta 1 (TGFβ1) is mapped (Yerle et al. 
1990). This gene might be one important candidate for LW related traits since TGFβ1 is 
a potent regulator of cell proliferation and contributes to the differences in size and 
shape of the limb (Thorp et al. 1995). The QTL for FFS was found on SSC16 at 33 cM 
close to one of the previously reported QTL (27 cM) for rear leg score (Guo et al. 
2009). In addition, the QTL for FFS on SSC16 was described previously at 61 cM (Lee 
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et al. 2003). We found QTL for OC score at CMH on SSC5 at 159 cM but Andersson-
Eklund et al. (2000) reported QTL for OC at 51 cM on the same chromosome. The 
functional candidate gene matrix gla protein (MGP) for OC (Laenoi et al. 2010) is 
located in this chromosome. The QTL on SSC2 at 0 cM close to the marker SW2443 
(SSC2p17) was the most significant and the only QTL detected for BMC. Close to this 
chromosomal region at 7 cM a QTL was also found for BMD, providing a promising 
chromosomal region to identify genes responsible for bone mineral-related traits. Since 
BMD and BMC is highly correlated, this QTL could be pleiotropic influencing both of 
these traits. One of the highest linkage to reach the 5% genome-wide level significance 
for BMD was found on SSC3 at 82 cM. This QTL is novel and does not overlap with 
QTL reported by previous studies. A potential candidate gene in this chromosomal 
region includes the follicle-stimulating hormone receptor (FSHR) - a direct regulator of 
bone mass (Xu et al. 2009). However, large confidence regions in this experiment is a 
problem in this QTL study, which hampered the interpretation of QTL results since this 
region could contain many of potential candidate genes (de Koning et al. 2005).   
 
Most of the identified QTL showed larger dominant effects rather than additive affects. 
In the same population of this study, 31 QTL out of 71 QTL for growth, fatness, 
leanness and meat quality traits showed also higher dominant effects (Liu et al. 2007). 
Lee et al. (2003) also reported QTL for leg weakness-related traits mostly with 
dominant effects in Large white × Meishan pigs. In addition, by using principal 
components analysis, Andersson-Eklund et al. (2000) also identified QTL regions for 
OC with significant and large effect of overdominance. The explanation might be that 
maternal or common environment effects can be partially confounding (Rowe et al. 
2008). The dominance effect is an important source of variation in complex traits but 
dominance has sometimes been ignored (de Koning et al. 2005, Zhang et al. 2008). 
Moreover, most of the traits or diseasess related to skeletal system such as osteoporosis 
(Little et al. 2002), hypophosphatasia (Mornet 2007) and osteoarthritis (Meulenbelt et 
al. 1997, Stock et al. 1999), are inpart inherited in an autosomal dominant pattern. The 
results from this study and previously reported suggest that dominance plays a role in 
the genetic control of leg weakness related traits. Therefore, identification of dominance 
QTL effects in our study supported the mode of inheritance for the leg weakness related 
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traits and is valuable for the further detection of candidate genes. However, it is 
important to note that the low heritability of these traits also revealed that they are 
complex and may be under polygenetic control primarily by non-additive gene action or 
importantly affected by a major gene with Mendelian transmission (Kadarmideen and 
Janss 2005). In this study most of the QTL were identified as a single-trait region for 
each of the traits and were few in number. This could explain the low phenotypic 
correlations between the traits observed in the population. Different QTL for leg and 
feet scores were observed in this study, implying that these traits are controlled by 
multiple gene action. Our results showed novel linkage regions and also support some of 
the linkage regions previously reported. Though, the confidence intervals were large, 
these results will help for fine mapping and future identification of candidate genes in 
these QTL regions using additional markers or polymorphisms of genes located in the 
identified regions regarding leg weakness-related traits in pigs.   
 
5.3 Association of candidate genes with leg weakness related traits 
In this study we tested whether polymorphisms in the genes controlling chondrocyte 
metabolism may explain parts of the observed phenotype variation in susceptibility to 
LW. Sequence comparisons among three pig breeds revealed one SNP in 3´UTR of the 
porcine COL10A1 gene which was reported previously by Madsen et al.  (2003) as well 
as the SNP found in intron 6 of the porcine TGFβ1 (Wimmers et al. 2002). Statistically 
significant (P < 0.01) association was found between TGFβ1 g.180 G>A polymorphism 
and rear leg score. Recently, a SNP at intron 9 of TGFβ1 was reported to be associated 
with body length in pigs (Fan et al. 2009). This indicates that TGFβ1 might be 
associated with the structural soundness in pigs, which is consistent with its major 
functions in the development and maintenance of both cartilage and bone metabolism 
(Janssens et al. 2005). Moreover, we found positive association of the MMP3 g.158 
C>T SNP with some of the OC scores and BMD in the DuPi population. To our 
knowledge, this is the first association study of the MMP3 polymorphism with leg 
weakness related traits in pigs that makes it difficult to compare our result with the other 
findings. However in humans, MMP3 was found to be linked with different types of 
joint disease such as osteoarthritis (Kubota et al. 1997), suggesting that the association 
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of the MMP3 with the joint disease can occur also in pigs. In this study we found a 
significant additive effect of MMP3 g.158 C>T SNP on BMD, which indicated that the 
C allele of MMP3 gene was associated with the increase in bone mineral density. It is 
important to note that BMD can significantly contribute to the progression of 
osteoarthritis in humans (Betancourt et al. 2009, Hunter et al. 2009, Richette et al. 
2009).  
No significant association between SNP of COL10A1 and the LW-related traits in pigs 
could be detected in this study, suggesting that the investigated COL10A1 g.72 C>T 
SNP can be excluded as genetic marker for the LW-related traits at least in our 
population. Since this is the first study on the association of COL10A1 gene with leg 
weakness related traits in pigs, it is difficult to compare our results with literature data 
in pig. Previous study in dogs showed that a deletion in the COL10A1 gene was not 
associated with skeletal changes (Young et al. 2006). But association between 
COL10A1 polymorphism and osteoarthritis has been recently reported in humans 
(Lamas et al. 2010). Some of the SNP tested in this study deviated from HWE and this 
could have modestly affected the type I error of the analysis. Screening of genes with 
departure from HWE in data sets of affected individuals has been proposed as a 
relatively efficient method for detecting gene–disease associations (Salanti et al. 2005). 
Therefore, the generality of our finding could be limited. However, the departure from 
HWE for some SNP in our study may be due to the intensive selection of the used 
populations. 
In conclusion for the association results, this study demonstrated that TGFβ1 g.180 
G>A and MMP3 g.158 C>T polymorphisms may contribute to the susceptibility to 
traits related with leg weakness. The lack of consistence between results in DuPi and CP 
suggests that the association between SNP and LW-related traits can be depending on 
other causative mutations in linkage disequilibrium with the analyzed SNPs. Further 
confirming the involvement of this gene function involved in OC or LW development is 
needed. Association of TGFβ1 and MMP3 genes polymorphisms and their impact on 
leg weakness related traits, should be further validated in other populations.  
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5.4  Gene expression in porcine articular cartilage with and without OC lesion 
To further explore the relationship between candidate genes and OC occurrence in pigs, 
we investigated the gene expression between OC and healthy cartilage. Relative 
expression levels of genes known to be important in the regulation and involved in the 
endochondral ossification were examined. There was a significant increase of TGFβ1 
and RUNX2 in OC lesions compared to healthy cartilage, while MGP was significant 
decreased in OC cartilage. SOX9 showing non significant (but trend to) up regulation in 
OC lesions. Among the genes examined, the transcription factor SOX9 was highest 
expressed where MMP9 was lowest expressed in articular cartilage compared with the 
other genes. No changes were detected in the expression of COL2A1 and MMP9. The 
expression of these genes has been previously correlated with the variation of the OC 
lesion in pigs (Ohata et al. 2002, Thorp et al. 1995, Wardale and Duance 1994). The 
significant up regulation of TGFβ1 at OC lesions found in this study was in contrast 
with a previous report in pig (Thorp et al. 1995) in which this gene was found to be 
deficient in the chondrocytes at the sites of OC. However, it was in agreement with 
studies in horses (Henson et al. 1997, Semevolos et al. 2001) in which the expression of 
this gene was higher in OC lesions. TGFβ1 is generally considered as a stimulator of 
type II collagen. It is known as the main cellular component of articular cartilage. 
Therefore, down regulation of the gene encoding type II collagen can partially result in 
low quality of articular cartilage. In a previous study, the proportion of type II collagen 
in OC lesions from both osteochondrotic articular and growth plate cartilages was 
substantially decreased (Wardale and Duance 1994). Moreover, genetic variations of the 
gene COL2A1 encoding type II collagen have been reported to be associated with 
several types of joint diseases including OA (Uitterlinden et al. 2000, Valdes et al. 
2007). However, in this study, the expression of COL2A1 was not different between OC 
and healthy cartilage. Our result is also supported by a study in horses but not in pigs. 
The reason for this may be that the expression of structural genes such as COL2A1 and 
COL10A1 may not change in the early development of OC lesion and may not different 
from the normal cartilage. Regarding to a key transcription factor in cartilage formation, 
sex-determining region Y-type high mobility group box 9 (SOX9) was reported as a 
potent activator of type II collagen expression (Kypriotou et al. 2003, Ushita et al. 
2009). As recently reported, expression of SOX9 mRNA was decreased in osteoarthritic 
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chondrocytes compared to healthy cartilage (Orfanidou et al. 2009). However, in this 
study there was no difference in expression of SOX9 mRNA in OC lesions compared 
with healthy cartilage. In addition to SOX9, RUNX2 is another bone and cartilage 
specific transcription factor that has been intensively studied and might play an 
important role in the OC development. It is one of the important key transcription 
factors controling skeletogenesis (Karsenty 2008). RUNX2 gene expression and protein 
function are regulated at multiple levels, including transcription, translation and post-
translational modification (Jonason et al. 2009). It was hypothesized in this study that 
there may be an increase in RUNX2 gene expression in OC lesions. The fact that we 
observed the high expression of RUNX2 in OC lesions is consistent with findings in 
horses (Mirams et al. 2009), and also in human OA (Orfanidou et al. 2009). RUNX2 acts 
as a transcription factor for genes expressed in hypertrophic chondrocytes (Jonason et 
al. 2009); this means that in the formation of OC lesions, chondrocyte hypertrophy 
might be involved. Expression of MMP3 and COL10A1 genes in healthy versus OC 
cartilage were not statistically different in our study. The expression of MMP3 has been 
previously investigated in regard to cartilage degradation in human (Kubota et al. 
1997b). However, differential expression of the MMP3 gene between OC and healthy 
cartilage could not be confirmed in our study. We found that the expression of 
COL10A1 is consistent with the results of a previous report in horses (Semevolos et al. 
2001), but in contrast with results previously reported in pigs (Wardale and Duance 
1994) and in horses (Mirams et al. 2009). Collagen type X function may be related to 
the development of OC; according to the association and expression results of this 
study, COL10A1 gene expression is not associated with any of the leg weakness traits at 
least in our populations.  
  
Further research is therefore required to elucidate the precise mechanisms of 
chondrocyte hypertrophy on OC lesion development. Although, most of the previous 
studies both in human and animal have focused on OC lesions that cause clinical signs 
or the chronic stages of the disease. Since it has been well known that the matrix 
metalloproteinases (MMPs) are responsible for cartilage collagen breakdown (Davidson 
et al. 2006), it has been recently reported in dogs with OA that the expression of MMP9 
mRNA was increased in OA lesions (Clements et al. 2009). This means that if OC 
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progresses to OA, the expression of those enzymes must be up regulated. However, in 
this study we could detected a very low expression of MMP9 in our sample and there 
was not differential expression between the OC and the healthy groups. The reason may 
be that the articular cartilage samples used in this study are not rich the stage of OA.  
 
5.5  Molecular characterization of MGP as a candidate gene for OC 
Genes involved in maintaining the normal structure of the articular cartilage might be 
important factors in the pathogenesis of OC. Abnormal expression of genes causing 
disturbances in cartilage metabolism may lead to OC. MGP is regarded as one of the 
potent inhibitors of extracellular matrix calcification, indicating that it can disrupt bone 
and cartilage metabolism. However, we found that the staining intensity of MGP tend to 
decrease with age as the pattern of immunostaining was lower in the articular cartilage 
of 6 month-old pigs in comparison to new born and 2 month-old pigs. We found that 
cartilage canals regressed with age. Our immunoreactivity result showed that MGP is 
localized within/around the cartilage canal suggesting that it may be released either 
from chondrocytes or directly from the cells of the cartilage canals. With respect to the 
developing skeleton and during endochondral bone formation, MGP is found to be 
expressed during this process (Tuckermann et al. 2000), indicating that, a slight 
decrease of MGP expression might be normal in growing pigs. In this study, we 
speculated that the abnormal changes in the MGP expression might play a role in the 
process of cartilage canal regression during endochondral ossification leading to the 
development of OC. We found that the MGP at mRNA and protein levels was down-
regulated in articular cartilage with OC lesions compared with healthy cartilage. Our 
result is supported by the previous study in human, using an immunosorbent assay. 
Schurgers et al. (2005) found that the circulating MGP concentration in persons with 
disease of the cartilage (osteoarthritis) was significantly lower. In mammals, 
chondrocytes are responsible for maintaining the cartilage homeostasis. The change in 
MGP gene expression in maturing chondrocytes and the lower expression of MGP in 
proliferative and hypertrophic chondrocytes are reported to induce chondrocyte 
apoptosis (Newman et al. 2001). As a result, failure of chondrocytes to maintain the 
cartilage matrix could lead to the development of cartilage disease.  
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During animal growth, the extracellular matrix and the chondrocytes of cartilage 
undergo a maturation process. However, many growth factors and matrix molecules 
also take part in this process. Transforming growth factor-beta1 (TGFβ1) and 
parathyroid hormone related peptide (PTHrP) decrease the rate of chondrocyte 
maturation, while bone morphogenetic proteins (BMPs), thyroid hormone, and retinoic 
acid stimulate terminal differentiation of chondrocytes. MGP has been identified as an 
inhibitor of bone morphogenetic protein-2 and 4 (Yao et al. 2006). Furthermore, during 
bone growth, the invasion of cartilage by blood vessels is required and vascular 
endothelial growth factor (VEGF) plays important role in vasculogenesis (Ytrehus et al. 
2004a). Decreased levels of VEGF in the cartilage canals are reported to promote 
endothelial cell apoptosis, which leads to the disruption of blood supply to the growth 
cartilage and finally the development of OC (Ytrehus et al. 2004b). MGP has been 
shown to increase VEGF expression through increased TGFβ1 in bovine endothelial 
cells (Boström et al. 2004). VEGF plays an important role in the growth of new blood 
vessels which may explain the pathogenesis of the vascular abnormalities that are 
commonly found in OC. On the other hand, TGFβ1 is reported to stimulate both VEGF 
and MGP expression (Zhou et al. 1993). TGFβ1 is a secreted protein that performs 
many cellular functions, including the control of cell growth, proliferation and 
differentiation. Therefore, it can be speculated that down regulation of MGP decreases 
the level of VEGF which may contribute in the process of cartilage canal vessels 
regression and the development of OC. Moreover, TGFβ1 is found to be deficient in 
chondrocytes at the sites of porcine osteochondrosis (Thorp et al. 1995), suggesting that 
MGP expression differences are one of the important factors contributing to the 
development of OC in pigs. The expression of MGP may be required for reducing the 
cartilage canals as previously found in endothelial cells that MGP protein stimulates 
VEGF expression through enhancing TGFβ1 (Boström et al. 2004). Therefore, this 
result will improve our understanding how MGP contributes to OC development.  
 
Three SNPs in the porcine MGP were detected, but none was in the promoter. Thus, we 
questioned whether DNA methylation at different CG sites within the CpG islands 
might be responsible for the lower MGP expression. DNA methylation has been 
suggested to play a role in maintaining the stability of cell differentiation and in 
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regulating gene transcription. An extensive review on the role of epigenetics in the 
pathogenesis of osteoarthritis is described (Roach and Aigner 2007). DNA methylation 
levels of CpG-rich promoters of genes related to chondrocyte phenotype have been 
reported recently in humans (Ezura et al. 2009). We have analyzed the methylation 
patterns of CpG regions at the MGP promoter using genomic sequencing of bisulfite-
treated genomic DNA. To the best of our knowledge, this is the first report regarding 
DNA methylation patterns of one gene specifically related to the OC in pigs by using 
samples from healthy and OC articular cartilage of full-sib animals. DNA methylation 
differences were found between individuals. This difference was also found in different 
clones from the same animal which might be the cause of inter-individual variation. 
Consistent with the pattern of MGP expression, the result showed that the second, 
seventh, and ninth CG sites were highly methylated in OC compared with normal 
cartilage. No study has been dedicated to determine whether the methylation of MGP is 
responsible for permitting aberrant MGP gene transcription. It was stated earlier that 
methylation generally prevents binding of transcription factors and other DNA binding 
proteins (Roach and Aigner 2007). We found that, when the CG locations were 
compared with the transcription factor biding sites, the second CG is within a binding 
site of the SRY-related transcription factor whereas the fourth, fifth and tenth CG are 
located within the CDP-CR, est-1 and Th1 biding sites, respectively. One of SRY-related 
transcription factor that has been reported to play an important role in endochondral 
ossification is SOX9, which is a cartilage specific transcription factor (Tew et al. 2005). 
MGP mRNA and protein are down-regulated in the OC cartilage which might be due to 
the hyper methylation of its promoter. All these results suggested that MGP might play 
role in the pathogenesis of OC in pigs.   
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6  Summary 
 
 
The present study has been carried out to identify quantitative trait loci and candidate 
genes associated with leg weakness related traits in pigs, as well as to identify the 
differentially expressed genes in articular cartilage with osteochondrosis. For QTL 
analysis, a total of 310 F2 pigs from a Duroc x Pietrain resource population were 
genotyped with 82 genetic markers in this study. Fore and rear leg (FLS, RLS) and feet 
(FFS, RFS) were scored following a set of attributes in live animals. Osteochondrosis 
(OC) was histologically scored at the head and condylus medialis of the left femur (HF, 
CMF) and humerus (HH, CMH). Bone mineral density (BMD), bone mineral content 
(BMC) and bone mineral area (BMA) were measured in the whole ulna and radius 
bones using dual energy X-ray absorptiometry (DXA). Parity was found to have an 
effect on most of the traits and average daily gain was affecting the leg score. Parity, 
carcass length and slaughter weight were found to have effect on DXA traits, whereas 
parity and age were affecting OC score. The DXA traits were moderately to highly 
correlated with each other. OC was observed mostly in the CMF. A total of 16 
chromosomal QTL regions were identified for leg weakness related traits on ten porcine 
autosomes in this study. Our results confirmed some of previous studies and provided 
information on new QTL for leg weakness related traits in pigs. All QTL reached the 
5% chromosome-wide significance level. A QTL for BMD reached 1% chromosome-
wide significance level. QTL on SSC2 and SSC3 for BMC and HH, respectively, 
reached 5% genome-wide significance level, hence are worthwhile for further 
investigation. The knowledge of QTL affecting these traits will contribute towards a 
more understanding of the genetic background of leg weakness in pigs.  
 
Association studies for SNPs in the genes TGFβ1, MMP3 and COL10A1 were carried 
out using 310 F2 DuPi and additional 299-pigs of a commercial population. Association 
(P < 0.01) was found between SNP of TGFβ1 (g.180 G>A) with rear leg score in DuPi. 
Significant association was found between SNP of MMP3 (g.158 C>T) with OC at head 
of femur (P < 0.05) and bone mineral density (P < 0.05) in the DuPi population. 
However, the associations found in DuPi could not be confirmed in the commercial 
population. On the basis of histological results, six healthy and diseased castrated males 
were used for gene expression studies. Genes known to play a significant role in 
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endochondral ossification were analyzed. TGFβ1 and RUNX2 gene expression was 
higher in OC samples (P < 0.05) compared to healthy cartilage, while MGP expression 
was lower  in OC cartilage. Accordingly, the intensity of MGP protein band was lower 
(P < 0.05) in the OC group when quantified by Western blot.  Furthermore, one CpG 
region was identified in the MGP promoter and DNA methylation of three CpG sites 
was higher in OC compared with normal cartilage. This suggested that the high DNA 
methylation at specific CpG sites in the MGP promoter might be involved in the down 
regulation of MGP in OC. The expression of COL2A1, MMP9 and SOX9 mRNA was 
not different between OC and healthy cartilage. Immunofluorescence of normal 
cartilage collected from pigs of different ages revealed that MGP signals were higher in 
younger pigs and decreased in older pigs. The MGP protein was expressed closer to the 
cartilage canals. These results suggest that MGP, TGFβ1 and RUNX2 genes might be 
candidate genes for the development of OC in pigs.     
 
In conclusion, this study identified QTL regions underlying leg weakness related traits 
in a fast growing crossbreeds between Duroc and Pietrain pigs. These results will 
support the fine mapping and the future identification of candidate genes within these 
QTL regions. Some of the proposed candidate genes were found differentially expressed 
in healthy and OC cartilage, and associated with leg weakness traits. However, 
association results were not confirmed between populations. Taken together, these 
results will be helpful for the future understanding of the genetic and biological events 
that underly traits related with leg weakness in pigs. 
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7  Zusammenfassung 
 
 
Die Studie wurde durchgeführt, um QTLs und Kandidatengene, die mit den Beinschwäche-
Merkmalen beim Schwein in Verbindung stehen, zu identifizieren, so wie unterschiedlich 
exprimierte Gene in Gelenkknorpeln mit Osteochondrose aufzuzeigen. Für die QTL 
Analyse wurden in dieser Studie insgesamt 310 F2 Schweine aus einer Duroc×Piétrain 
Ressourcen Population mit Hilfe von 82 genetischen Markern genotypisiert. Mit Hilfe der 
linearen Fundamentbeurteilung war es möglich sowohl die Vorder- und Hinterbeine (FLS, 
RLS) als auch die Füße (FFS, RFS) zu bewerten. Der Osteochondrose (OC) Status wurde 
histologisch am Kopf  und Condylus medialis des linken Femurs (HF, CMF) und Humerus 
(HH, CMH) bewertet. Die Knochenmineraldichte (BMD), Knochenmineralgehalt (BMC) 
und die Knochenmineralfläche wurden an Ulna und Radius mittels Dual-Röntgen-
Absorptiometrie (DXA) gemessen. Die Trächtigkeit hatte einen Effekt auf die meisten 
Merkmale. Ebenfalls hatte die durchschnittliche tägliche Zunahme einen Einfluss auf die 
Fundamentbewertung. Außerdem hatten die Trächtigkeit, die Schlachtkörperlänge und das 
Schlachtgewicht einen Effekt auf die DXA-Merkmale, wohingegen die Trächtigkeit und 
das Alter den OC Status beeinflussten. Auch korrelieren die DXA Merkmale mittel bis 
stark untereinander. OC wurde am meisten bei den CMF beobachtet. In dieser Studie 
wurden insgesamt 16 chromosomale QTL Regionen auf 10 Autosomen für die 
Beinschwäche-Merkmale identifiziert. Unsere Ergebnisse bestärken einige vorherige 
Studien und liefern Informationen zu neuen QTLs für Beinschwäche-Merkmale beim 
Schwein. Alle QTLs erreichten ein chromosomweites Signifikanzniveau von 5%. Ein QTL 
für das BMD-Merkmal hatte ein chromosomweites Signifikanzniveau von 1% 
beziehungsweise erreichten die QTLs auf SSC2 und 3 für BMC und HH ein genomweites 
Signifikanzniveau von 5%. Diese Ergebnisse eignen sich für weitere Untersuchungen. Die 
Erkenntnisse über die QTLs, die diese Merkmale beeinflussen, könnte zu einem besseren 
Verständnis über den genetischen Hintergrund von Beinschwäche-Merkmalen beim 
Schwein führen. 
Die Assoziationsstudie zu den Genen TGFβ1, MMP3 und COL10A1 wurden bei den DuPi 
Tieren und 299 zusätzlichen Schweinen aus einer kommerziellen Population durchgeführt. 
Eine Assoziation (P<0,01) wurde zwischen dem SNP von TGFβ1 (g.180 G>A) und der 
Fundamentbeurteilung der Hinterbeine bei den DuPi Tieren festgestellt. Signifikante 
Assoziationen wurden zwischen dem SNP von MMP3 (g.158 C>T) und der OC Gruppe am 
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Femurkopf (P<0,05) sowie der BMD Gruppe (P<0,05) in der DuPi Population festgestellt. 
Allerdings konnte keine Assoziation zwischen den DuPi Tieren und der kommerziellen 
Population bestätigt werden. Auf der Basis von histologischen Ergebnissen, wurden 6 
gesunde und 6 kranke Börge für eine Expressionsstudie genutzt. Gene, die bekannt dafür 
sind, während der endochondralen Ossifikation eine signifikante Rolle zu spielen, wurden 
analysiert. Dabei wurde festgestellt, dass die Genexpression von TGFβ1 und RUNX2 höher 
in den OC-Proben (P<0,05) war als in den gesunden Knorpeln, während die Expression von 
MGP in den OC-Knorpeln geringer war. Zusätzlich wurde beim Western Blot eine 
geringere Intensität der MGP-Protein Bande bei der OC Gruppe (P<0,05) festgestellt. 
Weiterhin konnte für MGP eine CpG-Region im Promotor identifiziert werden. Dabei 
zeigte sich, dass die DNA-Methylierung von drei CpG Bindungsstellen in der OC Gruppe 
im Vergleich zu der Gruppe mit den gesunden Knorpeln höher war. Diese Ergebnisse 
zeigen, dass die erhöhte DNA-Methylierung an der spezifischen CpG Bindungsstelle im 
MGP Promotor für die Down-Regulierung von MGP bei OC verantwortlich sein könnte. 
Bei der Expression von COL2A1, MMP9, und SOX9 wurden keine Unterschiede 
zwischen den OC-Knorpeln und den gesunden Knorpeln festgestellt. Bei der 
Immunfluoreszenzuntersuchung von normalen Gelenkknorpeln, die von Schweinen 
unterschiedlichen Alters stammten, war das MGP-Signal am stärksten bei jungen 
Schweinen und nahm mit zunehmendem Alter ab. Die MGP Proteinexpression war um die 
Knorpel Kanäle am höchsten. Diese Ergebnisse zeigen, dass die Gene MGP, TGFβ1 und 
RUNX2 potentielle Kandidatengene für die Entwicklung von OC bei Schweinen sein 
könnten. 
 
Abschließend lässt sich sagen, dass die Studie erstmals QTL-Regionen beschreibt, denen 
Beinschwäche-merkmale bei schnellwachsenden Kreuzungen aus Duroc und Piétrain 
Schweinen zu Grunde liegen. Diese Ergebnisse könnten bei der zukünftigen Feinkartierung 
sowie Identifikation von Kandidatengenen innerhalb dieser QTL-Regionen helfen. Manche 
der vorgegebenen Kandidatengene wurden unterschiedlich in gesunden und OC-Knorpeln 
exprimiert und waren mit den Beinschwäche-Merkmalen assoziiert. Dennoch konnten die 
Assoziationsstudien zwischen den Populationen nicht bestätigt werden. Zusammengefasst 
lässt sich sagen, dass diese Ergebnisse in der Zukunft hilfreich bei dem Verständnis der 
genetischen und biologischen Ereignisse sein könnten, denen die Beinschwäche-Merkmale 
beim Schwein zu Grunde liegen. 
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